Liver Transplant

Publication


556. Chen C.Y., Chen C.L. *, Yong C.C., Ong A.D. Segment 8 hepatic vein reconstruction in a living donor after left hepatectomy. Hepatobiliary Surg Nutr. 2021 (in press)
555. Chen P.J., Nakano T., Lai C.Y., Chang K.C., Chen C.L., Goto S. Daily full spectrum light exposure prevents food allergy-like allergic diarrhea by modulating vitamin D3 and microbiota composition. npj Biofilms and Microbiomes 2021 (in press)
554. Liu Y.W., Yong C.C., Lin C.C., Wang C.C., Chen C.L., Cheng Y.F., Wang J.H., Yen Y.H. Liver resection in elderly patients with hepatocellular carcinoma: Age does matter. Updates in Surgery 2021 (in press)
553. Lin S.H., Eng H.L., Liu Y.W., Lin C.C., Yong C.C., Wang C.C., Chen C.L., Kuo F.Y., Cheng Y.F., Wang J.H., Yen Y.H., Liu T.T., Li W.F., Chen C.H. Characteristics and prognosis of patients with large well-differentiated hepatocellular carcinoma who have undergone resection. American Journal of Surgery 2021 (in press)
552. Liu Y.W., Yong C.C., Lin C.C., Wang C.C., Chen C.L., Cheng Y.F., Wang J.H., Ten Y.H. Six months as a cutoff time point to define early recurrence after liver resection of hepatocellular carcinoma based on post-recurrence survival. Updates Surg 73(2):399-409, 2021.
551. Wu M.Y., Kuo S.C., Chuang S.F., Yeh C.H., Yin S.M., Li W.F., Wang H.J., Chen C.L., Wang C.C., Lin C.C. Comparative study of the safety and efficacy of SMOFlipidvs non SMOFlipid as TPN for liver transplantation. Ann Med Surg (Lond) 63:102094, 2021.
550. Kuo F.Y., Liu Y.W., Lin C.C., Yong C.C., Wang C.C., Chen C.L., Cheng Y.F., Wang J.H., Yen Y.H.* Microscopic portal vein invasion is a powerful predictor of prognosis in patients with hepatocellular carcinoma who have undergone liver resection. Journal of Surgical Oncology 123(1):222-235, 2021.
549. Liu Y.W., Yong C.C., Lin C.C., Wang C.C., Chen C.L., Cheng Y.F., Wang J.H., Yen Y.H.*, Chen C.H. Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high-volume liver surgery center in East Asia. Journal of Surgical Oncology 122(8):1587-1594, 2020.
548. Chen Y.M., Yu T.W., Wang C.C., Huang K.T., Hsu L.W., Lin C.C., Liu Y.W., Li W.F., Chen C.L.*, Chen C.C.* Characteristics of psychosocial factors in liver transplantation candidates with alcoholic liver disease before transplantation: A retrospective study in a single center in Taiwan. International Journal of Environmental Research and Public Health 17(22):8696, 2020.
547. Ou H.Y., Wu Y.N., Yu C.Y., Chen C.L., Hsu H.W., Weng C.C., Tsang L.L.C., Huang T.L., Tong Y.S., Lim W.X., Cheng, Y.F.* Transarterial chemoembolization using 100-μm drug-eluting microspheres in patients with hepatocellular carcinoma: A prospective study and midterm follow-up. Journal of Vascular and Interventional Radiology 31(11):1784-1791, 2020.
546. Ou H.Y.*, Cheng Y.F., Chuang Y.H., Hsu H.W., Chen C.L., Lazo M.Z., Weng C.C., Yu C.Y., Tsang L.L.C., Huang T.L., Tong, Y.S. Quantification of functional MR predicts early response in post-doxorubicin drug-eluting beads chemoembolization for hepatocellular carcinoma. Digestive Diseases and Sciences 65(8):2433-2441, 2020.
545. Chiang H.W., Chuang T.C., Chen C.L., Tyan Y.S., Lin T.L., Tsang L.L.C., Tu J.A., Chou Y.H., Tsai H.Y., Chen T.R.* Effective dose for multiple and repeated radiation examinations in donors and recipients of adult-to-adult living donor liver transplants at a single center. European Journal of Radiology 129:109078, 2020.
544. Lin T.S., Co JS., Chen C.L.*, Ong A.D. Optimizing biliary outcomes in living donor liver transplantation: Evolution towards standardization in a high-volume center. Hepatobiliary and Pancreatic Diseases International 19(4):324-327, 2020.
543. Shih T.H., Chen C.C., Chen C.L., Huang C.J., Cheng K.W., Wang C.H., Wu S.C., Juang S.E., Jawan B., Yang S.C., Liu C.K., Hou S.Y.* Acute kidney injury in adult living donor liver transplantation performed with different methods of inferior vena cava clamping maneuvers. Transplantation Proceedings 52(6):1849-1851, 2020.
542. Cheng K.W., Chen C.C., Chen C.L., Wang C.H., Huang C.J., Wu S.C., Shih T.H., Yang S.C., Juang S.E., Hou S.Y., Jawan B., Liu C.K.* Comparison of glucose loads and blood glucose changes in patients with and without diabetes mellitus undergoing living donor liver transplantation. Transplantation Proceedings 52(6):1794-1797, 2020.
541. Wang C.H., Tsai C.E., Cheng K.W., Chen C.L., Huang C.J., Wu S.C., Shih T.H., Yang S.C., Juang S.E., Liu C.K., Jawan B., Hou S.Y.* Anesthetic fluid management of patients with hyponatremia undergoing living donor liver transplantation. Transplantation Proceedings 52(6):1798-1801, 2020.
540. Lin A.N., Ou H.Y., Huang T.L., Tsang L.C., Chen C.L., Cheng Y.F.* Management of biliary stricture in pediatric living donor liver transplantation recipients. Transplantation Proceedings 52(6):1844-1848, 2020.
539. Wang C.K., Cheng Y.F., Chen C.L., Ou H.Y.* Imaging diagnosis of biliary complications of ABO incompatibility in living donor liver transplantation. Transplantation Proceedings 52(6):1833-1837, 2020.
538. Chiu S.M., Tsai M.C., Lin C.Y.*, Chen C.H., Lu S.N., Hung C.H., Sheen I.S., Chien R.N., Lin C.L., Hu T.H.*, Cheng Y.F., Chen C.L. Serial changes of renal function after directly acting antivirals treatment for chronic hepatitis C: A 1-year follow-up study after treatment. PLoS One 15(4):e0231102, 2020.
537. Tsai M.C.*, Liu Y.Y., Lin C.C., Wang C.C., Wu Y.J., Yong C.C., Chen K.D., Chuah S.K., Yao C.C., Huang P.Y., Chen C.H., Hu T.H., Chen C.L. Gut microbiotadysbiosis in patients with biopsy-proven nonalcoholic fatty liver disease: A cross-sectional study in Taiwan. Nutrients 12(3):820, 2020.
536. Lai Q.*, Vitale A., Halazun K., Iesari S., Viveiros A., Bhangui P., Mennini G., Wong T., Uemoto S., Lin C.C., Mittler J., Ikegami T., Zhe Y., Zheng S.S., Soejima Y., Hoppe-Lotichius M., Chen C.L., Kaido T., Lo C.M., Rossi M., Soin A.S., Finkenstedt A., Emond J.C., Cillo U., Lerut J.* Identification of an upper limit of tumor burden for downstaging in candidates with hepatocellular cancer waiting for liver transplantation: A West-East collaborative effort. Cancers 12(2):452, 2020.
535. Huang P.H., Liao C.C., Chen M.H., Huang T.L., Chen C.L., Ou H.Y., Cheng Y.F.* Noncontrast magnetic resonance angiography clinical application in pre-liver transplant recipients with impaired renal function. Liver Transplantation 26(2):196-202, 2020.
534. Chiang P.L., Cheng Y.F., Huang T.L., Ou H.Y., Yu C.Y., Hsu H.W., Lim W.X., Chen C.L., Yong C.C., Tsang, L.L.C.* Intensive Doppler ultrasonography for early detection of hepatic artery thrombosis after adult living donor liver transplantation. Annals of Transplantation 25:e924336, 2020.
533. Huang K.T.*, Chen K.D., Hsu L.W., Kung C.P., Li S.R., Chen C.C., Chiu K.W., Goto S., Chen C.L. Decreased PEDF promotes hepatic fatty acid uptake and lipid droplet formation in the pathogenesis of NAFLD. Nutrients 12(1):270, 2020.
532. Lin C.Y., Lin C.C., Wang C.C., Chen C.L., Hu T.H., Hung C.H., Huang P.Y., Tsai M.C.* The ALBI grade is a good predictive model for very late recurrence in patients with hepatocellular carcinoma undergoing primary resection. World Journal of Surgery 44(1):247-257, 2020.
531. Liu Y.W., Lin C.C., Yong C.C., Wang C.C., Chen C.L., Wang J.H., Yen Y.H.* Prognosis after resection of single large hepatocellular carcinoma: Results from an Asian high-volume liver surgery center. PLoS One 15(3):e0230897, 2020.
530. Hsu L.W., Huang K.T., Nakano T., Chiu K.W., Chen K.D., Goto S., Chen C.L.* MicroRNA-301a inhibition enhances the immunomodulatory functions of adipose-derived mesenchymal stem cells by induction of macrophage M2 polarization. International Journal of Immunopathology and Pharmacology 34: 2058738420966092, 2020.
529. Lin T.S., Vishnu Prasad N.R., Chen C.L., Yang J.C., Chiang Y.C., Kuo P.J., Wang C.C., Wang S.H., Liu Y.W., Yong C.C., Cheng Y.F. What happened in 133 consecutive hepatic artery reconstruction in liver transplantation in 1 year? Hepatobiliary Surg Nutr. 8(1):10-18, 2019.
528. Huang V., Chen C.L. *, Lin Y.H., Lin T.S., Lin C.C., Wang S.H., Yong C.C., Chen C.Y., Cheng Y.F. Bilateral proficiency over time leads to reduced donor morbidity in living donor hepatectomy. Hepatobiliary Surg Nutr. 8(5):459-469, 2019.
527. Chiu K.W., Lin T.L., Yong C.C., Lin C.C., Cheng Y.F., Chen C.L. Endoscopic injection sclerotherapy for pediatric bleeding esophageal varices complicated by gastric vein, main portal vein, splenic mesenteric junction, and splenic vein occlusion: A case report. BMC Gastroenterol. 28; 19(1):37, 2019.
526. Tsai K.F., Li L.C., Hsu C.N., Lin C.C., Lin Y.H., Cheng Y.F., Wang C.C., Chen C.L. Effects of conversion from calcineurin inhibitors to Sirolimus or Everolimus on renal function and possible mechanisms in liver transplant recipients. J Clin Pharmacol. 59(3):326-334, 2019.
525. Ling L.L., Hsu C.C., Yong C.C., Elsarawy A.M., Chan Y.C., Wang C.C., Li W.F., Lin T.L., Kuo F.Y., Cheng Y.F., Lin L.M., Chen C.L., Lin C.C..FDG-PET predicted unfavorable tumor histology in living donor liver transplant recipients: A retrospective cohort study. Int J Surg. 69:124-131, 2019.
524. Tschuor C., Ferrarese A., Kuemmerli C., Dutkowski P., Burra P., Clavien P.A., Lendoire J., Imventarza O., Crawford M., Andraus W., D'Albuquerque L.A.C., Hernandez-Alejandro R., Dokus M.K., Tomiyama K., Zheng S., Echeverri G.J., Taimr P., Fronek J., de Rosner-van Rosmalen M., Vogelaar S., Lesurtel,M., Mabrut J.-Y., Nagral S., Kakaei F., Malek-Hosseini S.A., Egawa H., Contreras A., Czerwinski J., Danek T., Pinto-Marques H., Gautier S.V., Monakhov A., Melum E., Ericzon B.G., Kang K.J., Kim M.S., Sanchez-Velazquez P., Oberkofler C.E., Mullhaupt B., Linecker M., Eshmuminov D., Grochola L.F., Song Z., Kambakamba P., Chen C.L., Haberal M., Yilmaz S., Rowe I.A.C., Kron P., Liver Allocation Study Group. Allocation of liver grafts worldwide - Is there a best system? J Hepatol. 71(4):707-718, 2019.
523. Chuang Y.H., Ou H.Y., Yu C.Y., Chen C.L., Weng C.C., Tsang L.L., Hsu H.W., Lim W.X., Huang T.L., Cheng Y.F. Diffusion-weighted imaging for identifying patients at high risk of tumor recurrence following liver transplantation. Cancer Imaging. 19(1):74, 2019.
522. Nakano T., Chen I.H., Wang C.C., Chen P.J., Tseng H.P., Huang K.T., Hu T.H., Li L.C., Goto S., Cheng Y.F., Lin C.C., Chen C.L.*.Circulating exosomal miR-92b: Its role for cancer immunoediting and clinical value for prediction of posttransplant hepatocellular carcinoma recurrence. Am J Transplant. 19(12): 3250-3262, 2019.
521. Yen Y.H., Kuo F.Y., Lin C.C., Chen C.L., Chang K.C., Tsai M.C., Hu T.H.*. Predicting hepatic steatosis in living liver donors via controlled attenuation parameter. Transplant Proc. 50(10):3533-3538, 2018.
520. Huang K.T.*, Hsu L.W., Chen K.D., Kung C.P., Goto S., Chen C.L. Decreased PEDF expression promotes adipogenic differentiation through the up-regulation of CD36. Int J Mol Sci. 19(12), 2018.
519. Chiu K.W.*, Goto S., Nakano T., Hu T.H., Chen D.W., Huang K.T., Hsu L.W., Chen C.L. Genetic polymorphisms of the hepatic pathways of fatty liver disease after living donor liver transplantation. Liver Int. 38(12):2287-2293, 2018.
518. Nakano T.*, Goto S., Takaoka Y., Tseng H.P., Fujimura T., Kawamoto S., Ono K., Chen C.L. A novel moonlight function of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) for immunomodulation. Biofactors. 44(6):597-608, 2018.
517. Lin T.L., Kuo S.C., Yeh C.H., Chan Y.C., Lin Y.H., Li W.F., Yong C.C., Liu Y.W., Wang S.H., Lin C.C., Wang C.C.*, Chen C.L. Donor-transmitted bacterial infection in deceased donor liver transplantation: experience of Southern Taiwan Medical Center. Transplant Proc. 50(9):2711-2714, 2018.
516. Huang T.L.*, Chen T.Y., Tsang L.C., Ou H.Y., Yu C.Y., Hsu H.W., Lim W.X., Cheng Y.F., Chen C.L. Acoustic radiation force impulse elastography in post-transplant recurrent hepatitis C in living donor liver transplantation. Transplant Proc. 50(9):2695-2698, 2018.
515. Lin C.C., Ou H.Y., Chuang Y.H., Chiang H.J., Yu C.C., Lazo M., Tsang L.L., Huang T.L., Lin C.C., Chen C.L., Cheng Y.F.*. Diffusion-weighted magnetic resonance imaging in liver graft rejection. Transplant Proc. 50(9):2675-2678, 2018.
514. Shih T.H., Tsou Y.H., Huang C.J., Chen C.L., Cheng K.W., Wu S.C., Yang S.C., Juang S.E., Huang C.E., Lee Y.E., Jawan B., Wang C.H., Chang K.A.*. The correlation between CVP and SVV and intraoperative minimal blood loss in living donor hepatectomy. Transplant Proc. 2661-2663, 2018.
513. Wang C.H., Chang K.A., Chen C.L., Cheng K.W., Wu S.C., Huang C.J., Shih T.H., Yang S.C., Juang S.E., Huang C.E., Jawan B., Lee Y.E.*. Anesthesia management and fluid therapy in right and left lobe living donor hepatectomy. Transplant Proc. 50(9):2654-2656, 2018.
512. Yang S.C., Lee H.Y., Chen C.L., Huang C.J., Wang C.H., Cheng K.W., Wu S.C., Shih T.H., Huang C.E., Lee Y.E., Jawan B., Juang S.E., Lu H.F.*. Eye protection in liver transplantation patients under general anesthesia. Transplant Proc. 50(9):2651-2653, 2018.
511. Huang C.E., Lu H.F., Chen C.L., Wang C.H., Huang C.J., Cheng K.W., Wu S.C., Shih T.H., Yang S.C., Juang S.E., Jawan B., Lee Y.E., Lee H.Y.*. Comparison of core temperature changes between pediatric patients lying on regular operating room linen drapes and water-repellent sheepskin rug in living donor liver transplantation. Transplant Proc. 50(9):2648-2650, 2018.
510. Huang C.J., Chang C.H., Cheng K.W., Chen C.L., Wu S.C., Shih T.H., Yang S.C., Lee Y.E., Huang C.E., Jawan B., Wang C.H., Juang S.E.*. Correlation between blood transfusion and blood glucose levels in adult living donor liver transplantation. Transplant Proc. 50(9):2645-2647, 2018.
509. Tong Y.S., Huang T.L., Chen T.Y., Tsang L.L.C., Ou H.Y., Yu C.Y., Hsu H.W., Xiong L.W., Liao C.C., Eng H.L., Chen C.L., Cheng Y.F.*. Imaging validation of drug-eluting beads transarterial chemoembolization of hepatocellular carcinomas in living donor liver transplantation. Transplant Proc. 50(9):2622-2625, 2018.
508. Lin L.M., Kuo S.C., Chiu Y.C., Lin H.F., Kuo M.L., Elsarawy A.M., Chen C.L., Lin C.C.*. Cost analysis and determinants of living donor liver transplantation in Taiwan. Transplant Proc. 50(9):2601-2605, 2018.
507. Hsu H.W., Tsang L.L., Ou H.Y., Huang T.L., Chen T.Y., Yu C.Y., Lim W.X., Tong Y.S., Chen C.L., Cheng Y.F.*. Donor outcomes after liver donation in adult to adult living donor liver transplantation. Transplant Proc. 50(9):2588-2592, 2018.
506. Salvador N.G.A., Wee S.Y., Lin C.C.*, Wu C.C., Lu H.I., Lin T.L., Lee W.F., Chan Y.C., Lin L.M., Chen C.L. Clinical outcomes of tuberculosis in recipients after living donor liver transplantation. Ann Transplant. 23:733-743, 2018.
505. Chiu K.W.*, Lin T.L., Yong C.C.*, Lin C.C., Cheng Y.F., Chen C.L. Complications of percutaneous liver biopsy in living donor liver transplantation: Two case reports. Medicine (Baltimore). 97(40):e12742, 2018.
504. Wang P.W., Wu T.H., Pan T.L.*, Chen M.H., Goto S., Chen C.L. Integrated proteome and cytokine profiles reveal ceruloplasmin eliciting liver allograft tolerance via antioxidant cascades. Front Immunol. 9:2216, 2018.
503. Wu M.K., Hsu L.W., Huang K.T., Lin C.C., Wang C.C., Lin T.L., Li W.F., Goto S., Chen C.L.*, Chen C.C.*. Assessment of relevant factors with respect to psychosocial properties in potential living donor candidates before liver transplantation. Neuropsychiatr Dis Treat. 14:1999-2005, 2018.
502. Wang T.K., Kuo F.Y., Lee S.Y., Cheng Y.F., Elsarawy A.M., Lin C.C.*, Lin T.L., Chen C.L. Rebound thymic hyperplasia after liver transplantation for a child with biliary atresia; a case report. Pediatr Transplant. E13251, 2018.
501. Huang S.F.*, Chang I.C., Hong C.C., Yen T.C., Chen C.L., Wu C.C., Tsai C.C., Ho M.C., Lee W.C., Yu H.C., Shen Y.Y., Eng H.L., Wang J., Tseng H.H., Jeng Y.M., Yeh C.T., Chen C.L., Chen P.J., Liaw Y.F. Metabolic risk factors are associated with non-hepatitis B non-hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B. Hepatol Commun. 2(6):747-759, 2018.
500. Chiu K.W.*, Nakano T., Hu T.H., Chen K.D., Hsu L.W., Eng H.L., Cheng Y.F., Goto S., Chen C.L. Association between subclinical low serum 25(OH)D in donors and fatty liver disease in recipients after living donor liver transplantation. Biomed Res Int. 2018:4508085, 2018.
499. Komorowski A.L.*, Hsu C.C., Julka K.D., Vasavada B., Lin C.C., Wang C.C., Chen C.L.. AFP role in predicting recurrence of hepatocellular carcinoma after living donor liver transplantation in HCV patients. Neoplasma. 65(3):455-460, 2018.
498. Chen C.L.*, Cheng Y.F., Ou H.Y., Yong C.C., Lin T.S., Wang S.H., Lin C.C., Concejero A.M. Complete portal vein occlusion after cyanoacrylate sclerotherapy in biliary atresia treated by living donor liver transplantation with intraoperative portal vein stenting via segment 4 portal vein stump. Hepatobiliary Surg Nutr. 7(4):313-316, 2018.
497. Yong C.C., Elsarawy A.M., Wang S.H., Lin T.S., Wang C.C., Li W.F., Lin T.L., Kuo F.Y., Cheng Y.F., Chen C.L., Lin C.C.* The surgical challenges of salvage living donor liver transplantation for hepatocellular carcinoma: the cumulative experience of 100 cases - a retrospective cohort study and a propensity score analysis. Int J Surg. 54(Pt A):187-192, 2018.
496. Chiu K.W.*, Nakano T., Chen K.D., Hu T.H., Lin C.C., Hsu L.W., Chen C.L., Goto S. Identification of IL-28B genotype modification in hepatocytes after living donor liver transplantation by laser capture microdissection and pyrosequencing analysis. Biomed Res Int. 2018:1826140, 2018.
495. Wu Y.J., Wang S.H., Elsarawy A.M., Chan Y.C., Chen C.L., Cheng B.C., Li L.C., Chiu C.H., Lee Y.W., Lin Y.C., Wee S.Y., Pan C.C., Kao Y.Y., Chen Y.H., Lin H.W., Lin L.M., Lin C.C.* Prediction of the development of persistent massive ascites after living donor liver transplantation using a perioperative risk score. Transplantation. 102(6):e275-e281, 2018.
494. Sasaki M.*, Kuo F.Y., Huang C.C., Swanson P.E., Chen C.L., Chuang J.H., Yeh M.M. Increased expression of senescence-associated cell cycle regulators in the progression of biliary atresia an immunohistochemical study. Histopathology. 72(7):1164-1171, 2018.
493. Chuang Y.H., Ou H.Y., Lazo M.Z., Chen C.L., Chen M.H., Weng C.C., Cheng Y.F.* Predicting post-hepatectomy liver failure by combined volumetric, functional MR image and laboratory analysis. Liver Int. 38(5):868-874, 2018.
492. Chen C.L.*, Cheng Y.F., Huang V., Lin T.L., Chan Y.C., Ou H.Y., Yong C.C., Wang S.H., Lin C.C. P4 stump approach for intraoperative portal vein stenting in pediatric living donor liver transplantation: An innovative technique for a challenging problem. Ann Surg. 267(3):e42-e44, 2018.
491. Han H.S., Cho J.Y.*, Kaneko H., Wakabayashi G., Okajima H., Uemoto S., Soubrane O., Yong C.C., Chen C.L., Cheung T.T., Belli G., Kubo S., Wu Y.M., Chen K.H., Troisi R.I., Kwon C.H.D., Suh K.S., Soin A.S., Kim K.H., Cherqui D. Expert panel statement on laparoscopic living donor hepatectomy. Dig Surg. 35(4):284-288, 2018.
490. Cho J.Y., Han H.S.*, Kaneko H., Wakabayashi G., Okajima H., Uemoto S., Soubrane O., Yong C.C., Chen C.L., Cheung T.T., Belli G., Kubo S., Wu Y.M., Chen K.H., Troisi R.I., Kwon C.H.D., Suh K.S., Soin A.S., Kim K.H., Cherqui D. Survey results of the expert meeting on laparoscopic living donor hepatectomy and literature review. Dig Surg. 35(4):289-293, 2018.
489. Huang K.T., Kuo I.Y., Tsai M.C., Wu C.H., Hsu L.W., Chen L.Y., Kung C.P., Cheng Y.F., Goto S., Chou Y.W., Chen C.L., Lin C.C.*, Chen K.D.* Factor VII-induced MicroRNA-135a inhibits autophagy and is associated with poor prognosis in hepatocellular carcinoma. Mol Ther Nucleic Acids. 9:274-283, 2017.
488. Huang C.J., Cheng K.W., Chen C.L., Wu S.C., Shih T.H., Yang S.C., Juang S.E., Lee Y.E., Huang C.E., Jawan B., Wang C.H.* Clinical beneficial effects of using crystalloid only in recipients of living donor liver transplantation. Int J Environ Res Public Health. 14(11), 2017.
487. Wang C.H., Cheng K.W., Chen C.L., Wu S.C., Shih T.H., Yang S.C., Lee Y.E., Jawan B., Huang C.E., Juang S.E., Huang C.J.* Effect and outcome of intraoperative fluid restriction in living liver donor hepatectomy. Ann Transplant. 22:664-669, 2017.
486. Lin C.C.*, Elsarawy A.M., Li W.F., Lin T.L., Yong C.C., Wang S.H., Wang C.C., Kuo F.Y., Cheng Y.F., Chen C.L. Liver transplantation for high risk hepatocellular carcinoma after liver resection: A sequential or salvage approach? Ann Transplant. 22:602-610, 2017.
485. Chen C.C., Hsu L.W., Huang K.T., Goto S., Chen C.L., Nakano T.* Overexpression of Insig-2 inhibits atypical antipsychotic-induced adipogenic differentiation and lipid biosynthesis in adipose-derived stem cells. Sci Rep. 7(1):10901, 2017.
484. Nakano T.*, Hsu L.W., Lai C.Y., Takaoka Y., Inomata M., Kitano S., Chen C.L., Goto S.* Therapeutic potential of α-lipoic acid derivative, sodium zinc histidine dithiooctanamide, in a mouse model of allergic rhinitis. Int Forum Allergy Rhinol. 7(11):1095-1103, 2017.
483. Wang S.H., Loh P.Y., Lin T.L., Lin L.M., Li W.F., Lin Y.H., Lin C.C.*, Chen C.L. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft. Liver Transpl. 23(10):1266-1272, 2017.
482. Kuo F.Y., Huang H.Y., Chen C.L., Eng H.L., Huang C.C.* TFE3-rearranged hepatic epithelioid hemangioendothelioma-a case report with immunohistochemical and molecular study. APMIS. 125(9):849-853, 2017.
481. Li L.C., Hsu C.N.*, Lin C.C., Cheng Y.F., Hu T.H., Chen D.W., Lee C.H., Nakano T., Chen C.L. Proteinuria and baseline renal function predict mortality and renal outcomes after sirolimus therapy in liver transplantation recipients. BMC Gastroenterol. 17(1):58, 2017.
480. Goto S. *, Nakano T.*, Hsu L.W., Chiang K.C., Shimada Y., Goto T., Ohmori N., Sato S., Takaoaka Y., Magari Y., Kawamoto S. , Chen C.L. *. The significance of a nuclear protein as a moonlight protein: Diagnostic and therapeutic potentials in liver transplantation. Int J Surg Surgical Porced. 2: 117, 2017.
479. Nakano T.*, Chen I.H., Goto S., Lai C.Y., Tseng H.P., Hsu L.W., Chiu K.W., Lin C.C., Wang C.C., Cheng Y.F., Chen C.L.* Hepatic miR-301a as a liver transplant rejection biomarker? And its role for interleukin-6 production in hepatocytes. OMICS. 21(1):55-66, 2017.
478. Chang C.C., Chen Y.J., Huang T.H., Chen C.H., Kuo F.Y., Eng H.L., Yong C.C., Liu Y.W., Lin T.L., Li W.F., Lin Y.H., Lin C.C., Wang C.C.*, Chen C.L. Living donor liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma: experience of a single center. Ann Transplant. 22:115-120, 2017.
477.

Chen K.D., Huang K.T., Tsai M.C., Wu C.H., Kuo I.Y., Chen L.Y., Hu T.H., Chen C.L., Lin C.C.* Coagulation factor VII and malignant progression of hepatocellular carcinoma. Cell Death Dis. 7:e2110, 2016.

476. Chen C.C., Hsu L.W., Nakano T., Huang K.T., Chen K.D., Lai C.Y., Goto S.*, Chen C.L. * DHL-HisZn, a novel antioxidant, enhances adipogenic differentiation and antioxidative response in adipose-derived stem cells. Biomed Pharmacother. 84:1601-09, 2016.
475. Lin C.C., Chen C.L. * Living donor liver transplantation for hepatocellular carcinoma achieves better outcomes. HepatoBiliary Surg Nutr. 5(5):415-421, 2016.
474. Ali M.A., Li W.F., Wang J.H., Lin C.C., Chen Y.J., Lin T.L., Lin T.S., Lu S.N., Wang C.C.*, Chen C.L. Impact of pathological features of primary hepatocellular carcinoma on the outcomes of intrahepatic recurrence management: Single center experience from Southern Taiwan. HPB (Oxford). 18(10):851-860, 2016.
473. Chiang H.J., Chang W.P., Chiang H.W., Lazo M.Z., Chen T.Y., Ou H.Y., Tsang L.L., Huang T.L., Chen C.L., Cheng Y.F.*. Magnetic resonance spectroscopy in living-donor liver transplantation. Transplant Proc. 48(4):1003-6, 2016.
472. Tung Y.C., Cheng Y.F., Huang T.L., Chen T.Y., Ou H.Y., Yu C.Y., Hsu H.W., Chen C.L., Tsang L.L.*. Impact of different dominant hepatic vein patterns in left-lobe donors of adult living donor liver transplantation. Transplant Proc. 48(4):1012-4, 2016.
471. Tsang L.L., Tung Y.C., Hsu H.W., Ou H.Y., Yu C.Y., Huang T.L., Chen C.L., Cheng Y.F.*. Impact of graft type in living donor liver transplantation: remnant liver regeneration and outcome in donors. Transplant Proc. 48(4):1015-7, 2016.
470. Juang S.E., Huang C.E., Chen C.L., Wang C.H., Huang C.J., Cheng K.W., Wu S.C., Shih T.H., Yang S.C., Wong Z.W., Jawan B., Lee Y.E.*. Predictive risk factors in the development of intraoperative hyperkalemia in adult living donor liver transplantation. Transplant Proc. 48(4):1022-4, 2016.
469. Chen W.T., Liang J.L., Chen M.H., Liao C.C., Huang T.L., Chen T.Y., Tsang L.L., Ou H.Y., Hsu H.W., Lazo M.Z., Chen C.L., Cheng Y.F.*. Noncontrast magnetic resonance angiography using inflow sensitive inversion recovery technique for vascular evaluation in pre-liver transplantation recipients. Transplant Proc. 48(4):1032-5, 2016.
468. Wu Y.J., Lin C.C.*, Chang Y.M., Wang S.H., Lin Y.H., Lu H.I., Concejero A.M., Chen C.L., Lin T.L. Computed tomography as primary screening for appraisal of pulmonary small nodules in liver transplant candidates. Transplant Proc. 48(4):1036-40, 2016.
467. Lin C.C., Cheng Y.F., Chiang H.J., Lazo M., Chang C.D., Tsang L.L., Yu C.Y., Hsu H.W., Chen W.T., Wang C.C., Liang J.L., Eng H.L., Chen C.L., Ou H.Y.*. Pharmacokinetic analysis of dynamic contrast-enhanced magnetic resonance imaging for distinguishing hepatocellular carcinoma from cholangiocarcinoma in pre-liver transplantation evaluation. Transplant Proc. 48(4):1041-4, 2016.
466. Yu C.Y., Ou H.Y., Weng C.C., Huang T.L., Chen T.Y., Leung-Chit L., Hsu H.W., Chen C.L., Cheng Y.F.*. Drug-eluting bead transarterial chemoembolization as bridge therapy for hepatocellular carcinoma before living-donor liver transplantation. Transplant Proc. 48(4):1045-8, 2016.
465. Shih T.H., Huang C.E., Lee Y.E., Chen C.L., Wang C.H., Huang C.J., Cheng K.W., Wu S.C., Juang S.E., Jawan B., Yang S.C.*. Preoperative portal vein velocity/size and effect on living donor liver transplantation recipient hemodynamics during inferior vena cava clamping. Transplant Proc. 48(4):1049-51, 2016.
464. Lee Y.E., Huang C.E., Yang S.C., Chen C.L., Wang C.H., Huang C.J., Cheng K.W., Wu S.C., Shih T.H., Wong Z.W., Jawan B., Juang S.E.*. Relationship between patients with or without a history of esophageal varices bleeding and the changes in hemodynamics during inferior vena cava clamping in living donor liver transplantation. Transplant Proc. 48(4):1052-4, 2016.
463. Li W.F., Lin T.L., Tan T.J., Alikhanov R.B., Yong C.C., Wang S.H., Lin C.C., Liu Y.W., Wang C.C.*, Chen C.L. Short-term total hepatic vascular exclusion in difficult caudate lobe dissection in living-donor liver transplantation recipients. Transplant Proc. 48(4):1059-62, 2016.
462. Cheng K.W., Ma C.W., Chen C.L., Wang C.H., Huang C.J., Shih T.H., Yang S.C., Juang S.E., Lee Y.E., Wong Z.W., Jawan B., Huang C.E., Wu S.C.*. Retrospective cohort study to compare anesthesia in living donor liver transplantation recipients who received single and dual liver grafts. Transplant Proc. 48(4):1071-3, 2016.
461. Lim K.I., Liu C.K., Chen C.L., Wang C.H., Huang C.J., Cheng K.W., Wu S.C., Shih T.H., Yang S.C., Lee Y.E., Jawan B., Juang S.E.*. Transitional study of patient-controlled analgesia morphine with ketorolac to patient-controlled analgesia morphine with parecoxib among donors in adult living donor liver transplantation: A single-center experience. Transplant Proc. 48(4):1074-6, 2016.
460. Shih T.H., Huang C.E., Chen C.L., Wang C.H., Huang C.J., Cheng K.W., Wu S.C., Juang S.E., Lee Y.E., Wong Z.W., Jawan B., Yang S.C.*. Correlation between changes in end-tidal carbon dioxide concentration and cardiac output during inferior vena cava clamping and unclamping in living-donor liver transplantation. Transplant Proc. 48(4):1077-9, 2016.
459. Lim K.I., Chiu Y.C., Chen C.L., Wang C.H., Huang C.J., Cheng K.W., Wu S.C., Shih T.H., Yang S.C., Juang S.E., Huang C.E., Jawan B., Lee Y.E.*. Effects of pre-existing liver disease on acute pain management using patient-controlled analgesia fentanyl with parecoxib after major liver resection: A retrospective, pragmatic study. Transplant Proc. 48(4):1080-2, 2016.
458. Wu C.H., Yong C.C., Liew E.H., Tsang L.L., Lazo M., Hsu H.W., Ou H.Y., Yu C.Y., Chen T.Y., Huang T.L., Concejero A.M., Chen C.L., Cheng Y.F.*. Combined hepatocellular carcinoma and cholangiocarcinoma: Diagnosis and prognosis after resection or transplantation. Transplant Proc. 48(4):1100-4, 2016.
457. Hsu H.W., Huang T.L., Cheng Y.F.*, Chen T.Y., Tsang L.L., Ou H.Y., Yu C.Y., Concejero A.M., Chen C.L. Sonographic evaluation of post-transplantation portal vein stenosis in pediatric living-donor liver transplant recipients with left-liver grafts. Transplant Proc. 48(4):1162-5, 2016.
456. Chang I.C.*, Huang S.F., Chen P.J., Chen C.L., Chen C.L., Wu C.C., Tsai C.C., Lee P.H., Chen M.F., Lee C.M., Yu H.C., Lo G.H., Yeh C.T., Hong C.C., Eng H.L., Wang J., Tseng H.H., Hsiao C.H., Wu H.D., Yen T.C., Liaw Y.F. The Hepatitis Viral Status in Patients With Hepatocellular Carcinoma: a Study of 3843 Patients From Taiwan Liver Cancer Network. Medicine (Baltimore).95(15):e3284, 2016.
455. Nakano T.*, Kamei R., Fujimura T., Takaoka Y., Hori A., Lai C.Y., Chiang K.C., Shimada Y., Ohmori N., Goto T., Ono K., Chen C.L., Goto S., Kawamoto S.* Impact of histone H1 on the progression of allergic rhinitis and its suppression by neutralizing antibody in mice. PLoS One. 11(4):e0153630, 2016.
454. Chen P.T., Chen C.L., Lin L.T., Lo C.H., Hu C.J., Chen R.P.*, Wang S.S.* Design of peptide substrate for sensitively and specifically detecting two Aβ-degrading enzymes: Neprilysin and angiotensin-converting enzyme. PLoS One. 11(4):e0153360, 2016.
453. Yong C.C., Tsai M.C., Lin C.C.*, Wang C.C., Lu S.N., Hung C.H., Hu T.H., Chen C.L. Comparison of salvage living donor liver transplantation and local regional therapy for recurrent hepatocellular carcinoma. World J Surg. 40(10):2472-80, 2016.
452. Chiu K.W.*, Nakano T., Chen K.D., Lin C.C., Hu TH, Goto S., Chen C.L. Association of IL28B SNPs rs12979860 and rs8099917 on hepatitis C virus-RNA status in donors/recipients of living donor liver transplantation. PLoS One. 11(6):e0156846,2016.
451. Hsu C.C.*, Chen C.L., Wang C.C., Lin C.C., Yong C.C., Wang S.H., Liu Y.W., Lin T.L., Lee W.F., Lin Y.H., Chan Y.C., Wu Y.J., Eng H.L., Cheng Y.F. Combination of FDG-PET and UCSF criteria for predicting HCC recurrence after living donor liver transplantation. Transplantation. 100(9):1925-32, 2016.
450. Rossler F., Sapisochin G., Song G., Lin Y.H., Simpson M.A., Hasegawa K., Laurenzi A., Sanchez Cabus S., Nunez M.I., Gatti A., Beltrame M.C., Slankamenac K.,Greig P.D., Lee S.G., Chen C.L., Grant D.R., Pomfret E.A., Kokudo N., Cherqui D., Olthoff K.M., Shaked A., Garcia-Valdecasas J.C., Lerut J., Troisi R.I., De Santibanes M., Petrowsky H., Puhan M.A., Clavien P.A.* Defining benchmarks for major liver surgery: A multicenter analysis of 5202 living liver donors.Ann Surg. 264(3):492-500, 2016.
449. Palaniappan N., Chen C.L.*. Living donor liver transplantation- “An experts cumulative insight from Taiwan”. Cell & Tissue Transplantation & Therapy 2016:8 1–6.
448. Chen K.D.*, Huang K.T., Lin C.C., Weng W.T., Hsu L.W., Goto S., Nakano T., Lai C.Y., Kung C.P., Chiu K.W., Wang C.C., Cheng Y.F., Ma Y.Y., Chen C.L.* MicroRNA-27b enhances the hepatic regenerative properties of adipose-derived mesenchymal stem cells. Mol Ther Nucleic Acids. 5:e285, 2016.
447. Pahari H., Li W.F., Lin T.S., Wang C.C. *, Yong C.C., Lin T.L., Lin C.C., Liu Y.W., Lin Y.H., Concejero A.M., Jawan B., Chen C.L.. Extensive adhesions in living donor liver transplantation: A retrospective analysis. World J Surg.40(2):427-32, 2016.
446. Lin T.L., Alikhanov R., Kuo S.C., Li W.F., Chen C.L., Wang S.H., Lin C.C., Liu Y.W., Yong C.C., Lin Y.H., Wang C.C. * Less cost by using hanging maneuver and Pringle maneuver in left lateral hepatectomy through small laparotomy wound-experience of Southern Taiwan.World J Surg Oncol.14(1):6, 2016.
445. Wu Y.J., Lin Y.H., Yong C.C., Li W.F., Wang S.H., Wang C.C., Lin T.L., Chen C.L., Lin C.C. * Safe one-to-one dosage conversion from twice-daily to once-daily tacrolimus in long-term stable recipients after liver transplantation. Ann Transplant.21:30-4, 2016.
444. Komorowski A.L., Li W.F., Millan C.A., Huang T.S., Yong C.C., Lin T.S., Lin T.L., Jawan B., Wang C.C. *, Chen C.L.Temporary abdominal closure and delayed biliary reconstruction due to massive bleeding in patients undergoing liver transplantation: an old trick in a new indication.J Hepatobiliary Pancreat Sci 23(2):118-24, 2016.
443. Pillai V.G., Chen C.L. * Living donor liver transplantation in Taiwan - Challenges beyond surgery. Hepatobiliary Surg Nutr. 5(2):145-50, 2016.
442. Tsai M.C., Chen K.D., Wang C.C., Huang K.T., Wu C.H., Kuo I.Y., Chen L.Y., Hu T.H., Goto S., Nakano T., Dorling A., McVey J.H., Chen C.L., Lin C.C.* Factor VII promotes hepatocellular carcinoma progression through ERK-TSC signaling. Cell Death Discov. 1:15051, 2015.
441. Tong M.S., Chai H.T., Liu W.H., Chen C.L., Fu M., Lin Y.H., Lin C.C., Chen S.M.*, Hang C.L. Prevalence of hypertension after living-donor liver transplantation: a prospective study.Transplant Proc. 47(2):445-50, 2015.
440. Wu Y.J., Lin C.C. *, Lin Y.H., Wang S.H., Lin T.L., Chen C.L., Concejero A.M., Chang Y.M., Lu H.I., Wu C.C.Incidentally Small Pulmonary Nodule in Candidates for Living Donor Liver Transplantation.Ann Transplant. 20:734-40, 2015.
439. Lin C.C., Yong C.C., Chen C.L. * Active vaccination to prevent de novo hepatitis B virus infection in liver transplantation. World J Gastroenterol 21(39): 11112-11117, 2015.
438. Hsu L.W., Nakano T., Huang K.T., Chen C.C., Chen K.D., Lai C.Y., Yang S.M., Lin C.C., Wang C.C., Cheng Y.F., Chiu K.W., Kuo Y.R., Goto S., Chen C.L. Prolonged survival by combined treatment with granulocyte colony-stimulating factor and dipeptidyl peptidase IV inhibitor in a rat small-for-size liver transplantation model. Hepatol Res. 45(7):804-13, 2015.
437. Ali M.A., Chuang J.F., Yong C.C., Wang C.C. *, Lin C.Y., Chen C.L. Extended central hepatectomy with preservation of segment 6 for patients with centrally located hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 14(1):63-8, 2015.
436. Chan Y.C., Kabiling C.S., Pillai V.G., Aguilar G., Wang C.C. *, Chen C.L. Survival outcome between hepatic resection and transarterial embolization for hepatocellular carcinoma more than 10 cm: A propensity score model. World J Surg. 39(6):1510-8, 2015.
435. Ali M.A., Yong C.C., Eng H.L., Wang C.C. *, Lin T.L., Li W.F., Wang S.H., Lin C.C., Yap A., Chen C.L. Cryopreserved arterial grafts as a conduit in outflow reconstruction in living donor liver transplantation. J Hepatobiliary Pancreat Sci.  22(6):498-504, 2015.
434. Lin W.C. *, Hsu T.W., Chen C.L., Lu C.H., Chen H.L., Cheng Y.F. Resting state-fMRI with ReHo analysis as a non-invasive modality for the prognosis of cirrhotic patients with overt hepatic encephalopathy.PLoS One. 10(5):e0126834, 2015.
433. Chiu K.W. *, Nakano T., Chen K.D., Hsu L.W., Lai C.Y., Huang C.Y., Cheng Y.F., Goto S., Chen C.L. Cytochrome P450 in living donor liver transplantation. J Biomed Sci. 15;22:32, 2015.
432. Chiu K.W. *, Nakano T., Chen K.D., Hsu L.W., Lai C.Y., Huang C.Y., Cheng Y.F., Goto S., Chen C.L. Repeated-measures implication of hepatocellular carcinoma biomarkers in living donor liver transplantation. PLoS One. 10(5):e0124943, 2015.
431. Chen C.J., Tang K.S., Huang Y.H., Chen C.L., Huang L.T., Chuang J.H., Tiao M.M. * The Characteristics of Antioxidant Activity after Liver Transplantation in Biliary Atresia Patients. Biomed Res Int.  2015:421413, 2015.
430. Yang S.C., Huang C.J., Chen C.L., Wang C.H., Wu S.C., Shih T.H., Juang S.E., Lee Y.E., Jawan B., Cheng Y.F., Cheng K.W. * Living donor liver transplantation with body-weight more or less than 10 kilograms. World J Gastroenterol.  21(23):7248-53, 2015.
429. Vasavada B. *, Chen C.L. Vascular complications in biliary atresia patients undergoing living donor liver transplantation: Analysis of 110 patients over 10 years. J Indian Assoc Pediatr Surg.  20(3):121-6, 2015.
428. Jao T., Schroter M., Chen C.L., Cheng Y.F., Lo C.Z., Chou K.H., Patel A.X., Lin W.C. *, Lin C.P. *, Bullmore E.T. Functional brain network changes associated with clinical and biochemical measures of the severity of hepatic encephalopathy. Neuroimage.  122:332-344, 2015.
427. Kuo F.Y., Huang C.C., Chen C.L., Chuang J.H., Riehle K., Swanson P.E., Yeh M.M.* Immunohistochemical characterization of the regenerative compartment in biliary atresia: a comparison between Kasai procedure and transplant cases. Hum Pathol. 46(11):1633-9, 2015.
426. Chen C.L. *, Concejero A.M. Safety Using Small Graft: Eastern Perspective. Liver Transpl. 21:S17-19, 2015.
425. Shih T.H., Huang C.J., Chen C.L., Cheng K.W., Wu S.C., Yang S.C., Juang S.E., Lee Y.E., Jawan B., Wang C.H.* Impact of Early Release of the IVC Clamp from Different IVC Clamping Maneuvers on Changes in Hemodynamic Parameters in Living Donor Liver Transplantation. Ann Transplant. 20:519-25, 2015.
424. Lin C.H., Chen C.L., Lin T.K., Chen N.C., Tsai M.H., Chuang Y.C. * Levetiracetam in the treatment of epileptic seizures after liver transplantation. Medicine (Baltimore).  94(38):e1350, 2015.
423. Chen C.L.* Balancing the risks of the elderly donor with recipient benefits in LDLT. Am J Transplant. 15: 15-16, 2015.
422. Wang C.H., Cheng K.W., Chen C.L., Wu S.C., Shih T.H., Yang S.C., Jawan B., Huang C.J.* The Effectiveness of prophylactic attachment of adhesive defibrillation pads in adult living donor liver transplantation. Ann Transplant. 20:97-102, 2015.
421. Jawan B.*, Wang C.H., Chen C.L., Huang C.J., Cheng K.W., Wu S.C., Shih T.H., Yang S.C.Review of anesthesia in liver transplantation.Acta Anaesthesiol Taiwan. 52:185-196, 2014.
420. Yang S.C., Wang C.H., Chen C.L., Cheng K.W., Wu S.C., Shih T.H., Jawan B., Huang C.J. *Acquired Hyponatremia in Pediatric Living Donor Liver Transplantation. Ann Transplant. 19:609-613, 2014.
419. Wang C.H., Cheng K.W., Chen C.L., Wu S.C., Shih T.S., Jawan B., Huang C.J.* Should abnormal coagulation data found in thromboelastography be corrected during liver transplantation? Experience of two cases. Acta Anaesthesiol Taiwan. 52(1):43-45, 2014.
418. Lee C.N., Tiao M.M.*, Chen H.J., Concejero A., Chen C.L., Huang Y.H.Characteristics and outcome of liver transplantation in children with alagille syndrome: a single-center experience.Pediatr Neonatol. 55(2):135-138, 2014.
417. Julka K.D.*, Lin T.S., Chen C.L., Wang C.C., Komorowski A.L. Reconstructing single hepatic artery with two arterial stumps: biliary complications in pediatric living donor liver transplantation. Pediatr Surg Int. 30(1):39-46, 2014.
416. Chiang H.J., Lin L.H., Li C.W., Lin C.C., Chiang H.W., Huang T.L., Chen C.L., Cheng Y.F.* Magnetic resonance fat quantification in living donor liver transplantation. Transplant Proc.46 (3):666-8, 2014.
415. Yu P.Y., Chen M.H., Ou H.Y., Huang T.L., Yu C.Y., Chen C.L., Cheng Y.F.* Magnetic resonance angiographic inflow-sensitive inversion recovery technique for vascular evaluation before liver transplantation. Transplant Proc. 46(3):682-5, 2014.
414. Huang C.E., Yang S.C., Chen C.L., Cheng Y.F., Cheng K.W., Wang C.H., Wu S.C., Huang C.J., Jawan B., Shih T.H.* Can coronary vein size predict hemodynamic instability during inferior vena cava clamping in liver transplantation? Transplant Proc. 46(3):692-5, 2014.
413. Shih T.H., Yang S.C., Chen C.L., Wang C.H., Cheng K.W., Huang C.J., Jawan B., Wu S.C.* The change of respiratory compliance before and after removal of ascites in living donor liver transplantation. Transplant Proc.46 (3):730-2, 2014.
412. Lim W.X., Cheng Y.F., Huang T.L., Chen T.Y., Tsang L.L., Ou H.Y., Yu C.Y.*, Hsu H.W., Chen C.L. Graft regeneration in pediatric living donor liver transplantation. Transplant Proc. 46(3):767-9, 2014.
411. Liao C.C., Chen T.Y., Tsang L.C., Ou S.Y., Yu C.Y., Hsu H.W., Cheng Y.F., Chiu K.W., Eng H.L., Chen C.L., Huang T.L.* The acoustic radiation force impulse elastography evaluation of liver fibrosis in posttransplantation dysfunction of living donor liver transplantation. Transplant Proc. 46(3):876-9, 2014.
410. Chen C.C., Hsu L.W., Nakano T., Goto S.*, Chen C.L. Elevation of C-reactive protein level and its correlation with psychiatric comorbidities in recipients after liver transplantation. Transplant Proc. 46(3):894-6, 2014.
409. Lin L.M., Lin C.C.*, Chen C.L., Lin C.C. Effects of an education program on intensive care unit nurses' attitudes and behavioral intentions to advocate deceased donor organ donation. Transplant Proc. 46(4):1036-40, 2014.
408. Cheng Y.F.*, Ou H.Y., Yu C.Y., Tsang L.L., Huang T.L., Chen T.Y., Hsu H.W., Concerjero A.M., Wang C.C., Wang S.H., Lin T.S., Liu Y.W., Yong C.C., Lin Y.H., Lin C.C., Chiu K.W., Jawan B., Eng H.L., Chen C.L.* Interventional radiology in living donor liver transplant. World J Gastroenterol. 20(20): 6221-5, 2014.
407. Takaoka Y., Goto S., Nakano T.*, Tseng H.P., Yang S.M., Kawamoto S., Ono K., Chen C.L. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) prevents lipopolysaccharide (LPS)-induced, sepsis-related severe acute lung injury in mice. Sci Rep.6; 4:5204, 2014.
406. Yap A.Q., Millan C.A., Wang J.H., Wang C.C.*, Lu S.N., Wang S.H., Lin C.C., Liu Y.W., Yong C.C., Li W.F., Lin T.L., Chen C.L. How to improve the outcome in patients with AJCC stage I hepatocellular carcinoma. Anticancer Res.34(6):3093-103, 2014.
405. Lin W.C., Chou K.H., Chen C.L., Chen H.L., Lu C.H., Li S.H., Huang C.C., Lin C.P., Cheng Y.F.* Longitudinal brain white matter alterations in minimal hepatic encephalopathy before and after liver transplantation. PLoS One. 28;9(8):e105887, 2014.
404. Hsu L.W., Nakano T., Huang K.T., Chen C.C., Chen K.D., Lai C.Y., Yang S.M., Lin C.C., Wang C.C., Cheng Y.F., Chiu K.W., Kuo Y.R., Goto S.*, Chen C.L.* Prolonged survival by combined treatment with granulocyte colony-stimulating factor and dipeptidyl peptidase IV inhibitor in a rat small-for-size liver transplantation model. Hepatol Res. 2014.
403. Lin W.C., Hsu T.W., Chen C.L., Lu C.H., Chen H.L., Cheng Y.F.*, Lin C.P.* Reestablishing brain networks in patients without overt hepatic encephalopathy after liver transplantation. J Cereb Blood Flow Metab. 34(12): 1877-86, 2014.
402. Chang C.D., Cheng Y.F., Chen T.Y., Tsang L.L., Ou H.Y., Yu C.Y., Hsu H.W., Chen C.L., Concejero A.M., Huang T.L.* Portal venous pressure in adult living donor liver transplantation. Transplant Proc. 46(3): 696-8, 2014.
401. Vasavada B.B.*, Chen C.L., Zakaria M. Portal flow is the main predictor of early graft dysfunction regardless of the GRWR status in living donor liver transplantation - a retrospective analysis of 134 patients. Int J Surg. 12(2):177-80, 2014.
400. Vasavada B.*, Chen C.L., Zakaria M. Using Low Graft/Recipient's Body Weight Ratio Graft With Portal Flow Modulation an Effective Way to Prevent Small-for-Size Syndrome in Living-Donor Liver Transplant: A Retrospective Analysis. Exp Clin Transplant. 12(5): 437-42, 2014.
399. Chen K.D., Hsu L.W., Goto S., Huang K.T., Nakano T., Weng W.T., Lai C.Y., Kuo Y.R., Chiu K.W., Wang C.C., Cheng Y.F., Lin C.C., Ma Y.Y., Chen C.L.* Regulation of heme oxygenase 1 expression by miR-27b with stem cell therapy for liver regeneration in rats. Transplant Proc. 46:1198-1200, 2014.
398.

Chen K.D., Wang C.C., Tsai M.C., Wu C.H., Yang H.J., Chen L.Y., Nakano T., Goto S., Huang K.T., Hu T.H., Chen C.L., Lin C.C.* Interconnections between autophagy and the coagulation cascade in hepatocellular carcinoma. Cell Death Dis. 22(5): e1244, 2014.

397.

Chen C.L.* The right posterior sector graft in living donor liver transplantation revisited. Liver Transpl. 20(9):1019-20, 2014.

396.

Zhu A.X., Kudo M., Assenat E., Cattan S., Kang Y.K., Lim H.Y., Poon R.T., Blanc J.F., Vogel A., Chen C.L., Dorval E., Peck-Radosavljevic M., Santoro A., Daniele B., Furuse J., Jappe A., Perraud K., Anak O., Sellami D.B., Chen L.T. Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial. JAMA. 2;312(1):57-67, 2014.

395.

Kabiling C.S., Chen C.L.*, Concejero A.M., Wang C.C., Wang S.H., Lin C.C., Liu Y.W., Yong C.C., Jawan B., Cheng Y.F.. Professional framework for liver transplantation for overseas patients: Traveling for living donor liver transplantation. Transplantation. 97(8): S75-79, 2014.

394.

Hu T.H., Chen C.L.*, Lin C.C., Wang C.C., Chiu K.W., Yong C.C., Liu Y.W., Eng H.L.. Combination of entecavir plus low-dose on-demand hepatitis B immunoglobulin is effective with very low hepatitis B recurrence after liver transplantation. Transplantation. 97(8): S53-59, 2014.

393.

Lin C.C., Kabiling C.S., Chen C.L.*, Lin Y.H., Liu Y.W., Wang C.C., Hu T.H., Chiu K.W.. Short-course pretransplant antiviral therapy is a feasible and effective strategy to prevent hepatitis C recurrence after liver transplantation in genotype 2 patients. Transplantation. 97(8): S47-53, 2014.

392.

Lin T.S., Chen C.L.*, Concejero A.M., Yap A.Q., Lin Y.H., Liu C.Y., Chiang Y.C., Wang C.C., Wang S.H., Lin C.C., Yong C.C., Cheng Y.F.. Technical details of microsurgical biliary reconstruction in living donor liver transplantation. Transplantation. 97(8): S34-36, 2014.

391.

Cheng Y.F., Ou H.Y., Yu C.Y., Tsang L.L., Huang T.L., Chen T.Y., Concejero A.M., Wang C.C., Wang S.H., Lin T.S., Liu Y.W., Yang C.H., Yong C.C., Chiu K.W., Jawan B., Eng H.L., Chen C.L.* Management of portal venous complications in pediatric living donor liver transplantation. Transplantation. 97(8): S32-34, 2014.

390.

Cheng Y.F., Yu C.Y., Ou H.Y., Tsang L.L., Huang T.L., Chen T.Y., Concejero A.M., Wang C.C., Wang S.H., Lin T.S., Liu Y.W., Yang C.H., Yong C.C., Chiu K.W., Jawan B., Eng H.L., Chen C.L.*. Image evaluation of fatty liver in living donor liver transplantation. Transplantation. 97(8): S3-6, 2014.

389.

Chen C.L.* Living donor liver transplantation: The Asian perspective. Guest editors’ commentary: Summit on Living Donor Liver Transplantation. Transplantation. 97(8): S2, 2014.

388.

Wang C.C.*, Lopez-Valdes S., Lin T.L., Yap A., Yong C.C., Li W.F., Wang S.H., Lin C.C., Liu Y.W., Lin T.S., Concejero A.M., Eng H.L., Henry D., Cheng Y.F., Jawan B., Chen C.L.. Outcomes of long storage times for cryopreserved vascular grafts in outflow reconstruction in living donor liver transplantation.Liver Transpl 20:173–181, 2014.

387. Lin Y.M., Chiang L.W., Wang S.H., Lin C.C., Chen C.L., Millan C.A. , Wang C.C.* Resection of an intra-operative ruptured hepatocellular carcinoma with continuous pringle maneuver and in situ hypothermic perfusion through the inferior mesenteric vein - a case report. World J Surg Oncol. 11:2, 2013.
386. Lin T.S.*, Yang J.C., Chen C.L.Hepatic artery reconstruction using radial artery interposition graft in living donor liver transplantation.Transpl Int.26(4):e28-30, 2013.
385. Wang J.H.*, Kuo Y.H., Wang C.C., Chen C.L., Cheng Y.F., Hsu H.C., Lu S.N.Surgical resection improves the survival of selected hepatocellular carcinoma patients in Barcelona clinic liver cancer stage C.Dig Liver Dis. 45:510-515, 2013.
384. Lin T.L., Lin Y.H., Chen C.L., Wang S.H., Lin C.C., Liu Y.W., Yong C.C., Lin T.S., Li W.F., Jawan B., Cheng Y.F., Chen T.Y., Concejero A.M., Chan Y.C., Wang C.C.*.Strategy of Intra-Operative Management of Low Portal Vein Flow in Paediatric Living Donor Liver Transplantation. Annals of Saudi Medicine 33:24-26, 2013.
383. Chan Y.C., Li W.F., Lin T.L., Anthony Q. Yap, Chen C.L., Wang S.H., Lin C.C., Liu Y.W., Yong C.C., Lin Y.H., Wang C.C.* Lin's clamp revisited: A safe model for training in liver resection. Formosan Journal of Surgery 46:42-47, 2013.
382. Tiao M.M., Liou C.W., Huang L.T., Wang P.W., Lin T.K., Chen J.B., Chou Y.M., Huang Y.H., Lin H.Y., Chen C.L., Chuang J.H.*. Associations of mitochondrial haplogroups b4 and e with biliary atresia and differential susceptibility to hydrophobic bile Acid. PLoS Genet. 9:e1003696, 2013.
381. Lin C.C., Wang C.C.*, Hung K.C., Chen C.L., Yong C.C., Young T.H., Kobayash E. Study of porcine hepatocyte-entrapped bioartificial liver in surgery-induced fulminant hepatic failure rabbits. Biochemical Engineering Journal 76:55-59, 2013.
380. Chen C.L.*, Kabiling C., Concejero A.M. Why does living donor liver transplantation flourish in Asia? Nature Reviews Gastroenterol Hepatol. 10:746-751, 2013.
379.

Chiu K.W., Nakano T., Chen K.D., Hsu L.W., Lai C.Y., Chiu H.C., Huang C.Y., Cheng Y.F., Goto S., Chen C.L. *. Homogeneous phenomenon of the graft when using different genotype characteristic of recipients/donors in living donor liver transplantation. World J Hepatol. 5(11): 642-648, 2013.

378. Lin K.H., Liu J.W., Chen C.L., Wang S.H., Lin C.C., Liu Y.W., Yong C.C., Lin T.L., Li W.F., Hu T.H., Wang C.C. *. Impacts of pretransplant infections on clinical outcomes of patients with acute-on-chronic liver failure who received living-donor liver transplantation. PLoS One. 8(9):e72893, 2013.
377.

Huang C.J., Cheng K.W., Chen C.L., Wu S.C., Shih T.H., Yang S.C., Jawan B., Wang C.H. *. Predictive factors for pediatric patients requiring massive blood transfusion during living donor liver transplantation. Ann Transplant. 18: 443-447, 2013.

376. Nakano T.*, Goto S., Lai C.Y., Hsu L.W., Tseng H.P.*, Chen K.D., Chiu K.W., Wang C.C., Cheng Y.F., Chen C.L. Induction of antinuclear antibodies by de novo autoimmune hepatitis regulates alloimmune responses in rat liver transplantation.Clin Dev Immunol. 413928, 2013.
375. Lin C.C., Chen C.C., Chen C.L.*, Huang T.L*. Association between serum C-reactive protein and albumin levels and psychiatric comorbidities in liver transplant recipients. Transplant Proc. 45(6):2337-40, 2013.
374. Chiu K.W.*, Nakano T., Chen K.D., Lai C.Y., Hsu L.W., Chiu H.C., Huang C.Y., Cheng Y.F., Goto S., Chen C.L.* Pyrosequencing to identify homogeneous phenomenon when using recipients / donors with different CYP3A5*3 genotypes in living donor liver transplantation. PLoS One. 8(8): e71314, 2013.
373.

Chen S.M., Chen C.L., Chai H.T., Yong C.C., Hsu H.W., Cheng Y.F., Fu M., Huang Y.T.A., Hang C.L.* High flow-mediated vasodilatation predicts pulmonary edema in liver transplant patients. Acta Cardiol Sin 29:261-270, 2013.

372.

Chiu K.W.*, Hu T.H., Nakano T., Chen K.D., Lai C.Y., Hsu L.W., Tseng H.P., Chiu H.C., Cheng Y.F., Goto S., Chen C.L.* Biological interactions of CYP2C19 genotypes with CYP3A4*18, CYP3A5*3, and MDR1-3435 in living donor liver transplantation recipients. Transplant Res. 2(1):6, 2013.

371. Nakano T., Chen C.L.*, Goto S.Nuclear antigens and auto / alloantibody responses: Friend or foe in transplant immunology. Clin Dev Immunol. 267156, 2013.
370. Chen K.D., Goto S., Hsu L.W., Lin T.Y., Nakano T., Lai C.Y., Chang Y.C., Weng W.T., Kuo Y.R., Wang C.C., Cheng Y.F., Ma Y.Y., Lin C.C., Chen C.L.* Identification of miR-27b as a novel signature from the mRNA profiles of adipose-derived mesenchymal stem cells involved in the tolerogenic response. PLoS One. 8(4): e60492, 2013.
369. Takaoka Y., Kawamoto S.*, Katayama A., Nakano T., Yamanaka Y., Takahashi M., Shimada Y., Chiang K.C., Ohmori N., Aki T., Goto T., Sato S., Goto S., Chen C.L., Ono K. Unexpected T cell regulatory activity of anti-histone H1 autoantibody: its mode of action in regulatory T cell-dependent and -independent manners. Biochem Biophys Res Commun. 431(2):246-52, 2013.
368. Yap A.Q., Chen C.L., Yong C.C., Kuo F.Y., Wang S.H., Lin C.C., Liu Y.W., Lin T.L., Li W.F., Millan C.A., Wang C.C. * Clinicopathological factors impact the survival outcome following the resection of combined hepatocellular carcinoma and cholangiocarcinoma. Surg Oncol. 22(1):55-60, 2013.
367. Chen C.L. *, Concejero A.M., Lin T.S. Microsurgical biliary reconstruction: A strategy to reduce biliary anastomotic complications in living donor liver transplantation. Ann Saudi Med.33(2): S19-21, 2013.
366. Chen C.L. *, Concejero A.M., Lin T.S., Lin Y.H., Chiang Y.C., Wang C.C., Wang S.H., Lin C.C., Liu Y.W., Yong C.C. Outcome of routine use of microsurgical biliary reconstruction in pediatric living donor liver transplantation. J Hepatobiliary Pancreat Sci. 20:492-497, 2013.
365. Lin T.S., Chen C.L.*, Concejero A.M., Yap A.Q., Lin Y.H., Liu C.Y., Chiang Y.C., Wang C.C., Wang S.H., Lin C.C., Yong C.C., Cheng Y.F. Early and long-term results of routine microsurgical biliary reconstruction in living donor liver transplantation. Liver Transpl. 19:207–214, 2013.
364. Lu L.S., Hung F.C., Chuah S.K., Chiu K.W.*, Hu T.H., Cheng Y.F., Chen C.L. Recurrent gastric varices bleeding after living-related liver transplantation successfully eradicated by splenic artery embolization. Hepatogastroenterology 59:1586-1588, 2012.
363. Chen W.T., Yu C.Y., Huang T.L., Chen T.Y., Leo Tsang L.C., Ou H.Y., Chen C.L., Cheng Y.F.* Does transarterial embolization improve survival for recurrent hepatocellular carcinoma after living donor liver transplantation? J Radiol Sci 37:101-104, 2012.
362. Kuo Y.R.*, Chen C.C., Goto S., Lin P.Y., Wei F.C., Chen C.L. Mesenchymal stem cells as immunomodulators in a vascularized composite allotransplantation. Clin Dev Immunol. 2012:854846, 2012.
361.

Wu S.C., Chen C.L., Wang C.H., Huang C.J., Cheng K.W.*, Shih T.H., Yang J.C., Jawan B.* Predictive factors associated with re-exploration for hemostasis in living donor liver transplantation. Ann Transplant. 17(4):64-71, 2012.

360.

Chen H.L., Tsang L.L., Concejero A.M., Huang T.L., Chen T.Y., Ou H.Y., Yu C.Y., Chen C.L., Cheng Y.F.*: Segmental regeneration in right-lobe liver grafts in adult living donor liver transplant. Clin Transplant. 26(5):694-8, 2012.

359.

Liang C.D., Concejero A.M., Ko S.F., Chen C.C., Wang C.C., Chen C.L.*: The impact of intrapulmonary shunting after liver transplantation in pediatric patients. J Formos Med Assoc. 2111(6):315-319, 2012.

358.

Lin W.C., Hsu T.W., Chen C.L., Wu C.W., Lu C.H., Chen H.L., Li S.H., Yeh P.Y., Cheng Y.F.*, Lin C.P.*: Connectivity of default-mode network is associated with cerebral edema in hepatic encephalopathy. PLoS One. 7(5):e36986, 2012.

357.

Ou H.Y., Chao P.H., Yu P.C., Wei Y.C., Chen C.L.*, Yu C.Y., Chiu T.M., Chang Y.C., Lai C.Y., Cheng Y.F.*: Quantification of macrovesicular and microvesicular hepatic steatosis in rats using 3.0-T 1H-magnetic resonance spectroscopy. Transplant Proc. 44(4):955-958, 2012.

356.

Lee H.Y., Lu C.H., Lu H.F., Chen C.L.*, Wang C.H., Cheng K.W., Wu S.C., Jawan B., Huang C.J.: Relationship between postoperative lung atelectasis and position of the endotracheal tube in pediatric living-donor liver transplantation. Transplant Proc. 44(4):875-877, 2012.

355.

Lin Y.H., Lin C.C., Wang C.C., Wang S.H., Liu Y.W., Yong C.C., Lin T.L., Li W.F., Concejero A.M., Chen C.L.*: The 4-week serum creatinine level predicts long-term renal dysfunction after adult living donor liver transplantation. Transplant Proc. 44(3):772-775, 2012 .

354.

Chen T.Y., Chen C.L.*, Huang T.L., Tsang L.L., Ou H.Y., Yu C.Y., Hsu H.W., Cheng Y.F.: Predictive factors for persistent splenomegaly and hypersplenism after adult living donor liver transplantation. Transplant Proc.44(3):752-754, 2012.

353.

Chiu K.W., Nakano T., Tseng H.P., Cheng Y.F., Jawan B., Eng H.L., Goto S., Chen C.L.*: Western blotting analysis for quantitative detection of CYP2C19 expression in liver tissues in the setting of living donor liver transplantation. Hepatogastroenterology. 59(115):805-808, 2012.

352.

Lin T.L., Chiang L.W., Chen C.L.*, Wang S.H., Lin C.C., Liu Y.W., Yong C.C., Lin T.S., Li W.F., Jawan B., Cheng Y.F., Chen T.Y., Concejero A.M., Wang C.C.: Intra-operative management of low portal vein flow in pediatric living donor liver transplantation. Transpl Int. 25(5):586-91, 2012.

351.

Li W.F., Lin T.S., Chen C.L.*, Concejero A.M., Wang S.H., Lin C.C., Liu Y.W., Yong C.C., Lin T.L., Wang C.C.: Using ileocolic artery for successful graft salvage in a recipient with hepatic artery thrombosis after living donor liver transplantation: case report. Transplant Proc. 44(2):581-582, 2012.

350.

Huang T.L., Chen T.Y., Tsang L.L., Ou H.Y., Yu C.Y., Wang C.C., Wang S.H., Lin C.C., Liu Y.W., Yong C.C., Chiu K.W., Eng H.L., Jawan B., Cheng Y.F., Chen C.L.*: Hemodynamics of portal venous stenosis before and after treatment in pediatric liver transplantation: evaluation with Doppler ultrasound. Transplant Proc. 44(2):481-483, 2012.

349.

Lu C.H., Tsang L.L., Huang T.L., Chen T.Y., Ou H.Y., Yu C.Y., Chen C.L.*, Cheng Y.F.: Biliary complications and management in pediatric living donor liver transplantation for underlying biliary atresia. Transplant Proc. 44(2):476-477, 2012.

348.

Huang H.W., Lu H.F., Chiang M.H., Chen C.L.*, Wang C.H., Cheng K.W., Jawan B., Huang C.J., Wu S.C.: Hemodynamic changes during the anhepatic phase in pediatric patient with biliary atresia versus glycogen storage disease undergoing living donor liver transplantation. Transplant Proc. 44(2):473-475, 2012.

347.

Yu C.Y., Ou H.Y., Huang T.L., Chen T.Y., Tsang L.L., Chen C.L.*, Cheng Y.F.: Hepatocellular carcinoma downstaging in liver transplantation. Transplant Proc. 44(2):412-414, 2012.

346.

Juang S.E., Huang H.W., Kao C.W., Chen C.L., Lu H.F., Cheng K.W., Huang C.J., Wu S.C., Jawan B., Wang C.H.*: Effect of university of wisconsin and histidine-tryptophan-ketoglutarate preservation solutions on blood potassium levels of patients undergoing living-donor liver transplantation. Transplant Proc. 44(2):366-368, 2012.

345.

Kao C.W., Wu S.C., Lin K.C., Chen C.L., Huang C.J., Cheng K.W., Jawan B., Wang C.H.*: Pain management of living liver donors with morphine with or without ketorolac. Transplant Proc. 44(2):360-362, 2012.

344.

Chiang H.J., Hsu H.W., Chen P.C., Chiang H.W., Huang T.L., Chen T.Y., Chen C.L., Cheng Y.F.*: Magnetic resonance cholangiography in living donor liver transplantation: comparison of preenhanced and post-gadolinium-enhanced methods. Transplant Proc. 44(2):324-327, 2012.

343.

Nakano T.*, Lai C.Y., Goto S., Hsu L.W., Kawamoto S., Ono K., Chen K.D., Lin C.C., Chiu K.W., Wang C.C., Cheng Y.F., Chen C.L.*: Immunological and Regenerative Aspects of Hepatic Mast Cells in Liver Allograft Rejection and Tolerance. PLoS One. 7(5):e37202, 2012.

342.

Kuo Y.R. *, Goto S., Chen C.C., Huang Y.T., Wang C.T., Tsai C.C., Chen C.L.: Immunomodulatory Effects of Bone Marrow-Derived Mesenchymal Stem Cells in a Swine Hemi-Facial Allotransplantation Model. PLoS One. 7(4):e35459,2012.

341.

Lu C.H., Chen T.Y., Huang T.L., Tsang LL.C., Ou H.Y., Yu C.Y., Chen C.L., Cheng Y.F. *: Regeneration and Outcome of Dual Grafts in Living Donor Liver Transplantation. Clin Transplant. 26(2):E143-8, 2012.

340.

Hsu L.W., Goto S., Nakano T., Chen K.D., Wang C.C., Lai C.Y., Hou C.H., Chang Y.C., Cheng Y.F., Chiu K.W., Chen C.C., Chen S.H., Chen C.L.*: The effect of exogenous histone H1 on rat adipose-derived stem cell proliferation, migration, and osteogenic differentiation in vitro. J Cell Physiol. 227(10):3417-25, 2012.

339.

Chen C.L.*, Yap A.Q., Concejero A.M., Liu C.Y.: All-in-one sleeve patch graft venoplasty for multiple hepatic vein reconstruction in living donor liver transplantation. HPB. 14(4): 274-278, 2012.

338.

Chen C.L.*, Concejero A.M., Ou H.Y., Cheng Y.F., Yu C.Y., Huang T.L.: Intraoperative portal vein stent placement in pediatric Living Donor Liver Transplantation. J Vasc Interv Radiol. 23(5):724-725, 2012.

337.

Wang J.H., Wang C.C., Hung C.H., Chen C.L., Lu S.N.*: Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma. J Hepatol. 56(2): 412-418, 2012.

336.

Chiu K.W., Nakano T., Hu T.H., Tseng H.P., Cheng Y.F., Jawan B., Eng H.L., Goto S., Chen C.L.*: Homogenous phenomenon of graft liver CYP2C19 genotypes after living donor liver transplantation. Eur J Clin Invest. 42(4): 352-356, 2012.

335.

Chen L.T.*, Chen M.F., Li L.A., Lee P.H., Jeng L.B., Lin D.Y., Wu C.C., Mok K.T., Chen C.L., Lee W.C., Chau G.Y., Chen Y.S., Lui W.Y., Hsiao C.F., Whang-Peng J, Chen P.J.: Long-Term Results of a Randomized, Observation-Controlled, Phase III Trial of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma Underwent Curative Resection. Ann Surg. 255(1): 8-17, 2012.

334.

Lin W.C., Chou K.H., Chen C.L., Chen C.H., Chen H.L., Feekes J.A., Hsu N.W., Li S.H., Cheng Y.F.*, Lin C.P.*: Significant volume reduction and shape abnormalities of the basal ganglia in cases of chronic liver cirrhosis. AJNR Am J Neuroradiol. 33(2):239-45, 2012.

333.

Tsang L.L., Chen C.L., Huang T.L., Chen T.Y., Ou H.Y., Eng H.L., Concejero A, Yu C.Y., Chen H.L., Cheng Y.F.*: Superparamagnectic iron oxide-enhanced magnetic resonance for tumor surveillance in cirrhotic liver before liver transplantation with explanted liver correlation. Transplant Proc. 43:1674-1677, 2011.

332.

Lin C.Y., Bora D., Tai W.C., Lin T.L., Li W.F., Liu C.Y., Chen C.L., Wang C.C.*: Duodenal Diverticular Bleeding After Endoscopic Retrograde Cholangiopancreatography: A Case Report and Review of The Literature. J Emerg Crit Care Med. 22:164-169, 2011.

331.

Chen C.L.*, Concejero A.M., Cheng Y.F.: More than a quarter of a century of liver transplantation in Kaohsiung Chang Gung Memorial Hospital. Clin Transpl. 213-221, 2011.

330.

Goto S., Nakano T., Hsu L.W., Chiang K.C., Lai C.Y., Kawamoto S., Ono K., Chen K.D., Ohmori N., Goto T., Sato S., Kuo Y.R., Wang C.C., Jawan B., Cheng Y.F., Chen C.L.*: Autoimmunity and liver transplantation immunology. Current Trends in Immunology. 12:1-11, 2011.

329.

Ou H.Y., Concejero A.M., Yu C.Y., Huang T.L., Chen T.Y., Tsang L.L., Chen C.L., Wang S.H., Cheng Y.F.*: Hepatic arterial embolization for massive bleeding from an intrahepatic artery pseudoaneurysm using N-butyl-2-cyanoacrylate after living donor liver transplantation. Transpl Int. 24(3):e19-22, 2011.

328.

Pan T.L.*, Wang P.W., Chen S.T., Fang J.Y., Hsu T.K., Sintupisut N., Goto S., Chen C.L.: Prospective highlights of serum glycoproteins in spontaneous tolerance after orthotopic liver transplantation. Clin Chim Acta. 412(7-8):604-613, 2011.

327.

Wang C.C.*, Yap A.Q., Chen C.L., Concejero A.M., Lin Y.H.: Comparison of major hepatectomy performed under intermittent Pringle maneuver versus continuous Pringle maneuver coupled with in situ hypothermic perfusion. World J Surg. 35(4):842-849, 2011.

326.

Juang S.E., Chen C.L., Liao W.T., Wang C.H., Cheng K.W., Huang C.J., Wang C.C., Concejero A.M., Wu S.C., Jawan B.*: Two cases of massive pleural effusion noted only after induction of anesthesia in living donor liver transplantation. J Anesth. 25(3):418-421, 2011.

325.

Liao H.L., Chen C.L., Wang C.H., Chen C.L., Huang C.J., Cheng K.W., Wang C.C., Concejero A.M., Wang S.H., Liu Y.W., Jawade K., Wu S.C., Jawan B.*: The method and accuracy of documentation of intraoperative fluids management in liver transplantation recipients. Ann Transplant. 16(1):34-38, 2011.

324.

Hsu H.W., Tsang L.L., Yap A., Huang T.L., Chen T.Y., Lin T.S., Concejero A.M., Ou S.Y., Yu C.Y., Chen C.L., Cheng Y.F.*: Magnetic resonance cholangiography in living donor liver transplantation. Transplantation. 92(1):94-99, 2011.

323.

Yang S.C., Chen C.L., Wang C.H., Huang C.J., Cheng K.W., Wu S.C., Jawan B.*: Intraoperative blood and fluid administration differences in primary liver transplantation versus liver retransplantation. Acta Anaesthesiol Taiwan. 49(2):50-53, 2011.

322.

Lin T.L., Yap A.Q., Wang J.H., Chen C.L., Iyer S.G., Low J.K., Lin C.C., Li W.F., Chen T.Y., Bora D., Lin C.Y., Wang C.C.*: Long term survival in patients with hepatocellular carcinoma directly invading the gastrointestinal tract: case reports and literature review. Surg Oncol. 20(4):e207-214, 2011.

321.

Kuo Y.R.*, Chen C.C., Goto S, Lee I.T., Huang C.W., Tsai C.C., Wang C.T., Chen C.L.: Modulation of immune response and T-cell regulation by donor adipose-derived stem cells in a rodent hind-limb allotransplant model. Plast Reconstr Surg. 128(6):661e-672e, 2011.

320.

Lin M.T., Chen C.L., Wang C.C., Cheng Y.F., Eng H.L., Wang J.H., Chiu K.W., Lee C.M., Hu T.H.*: Diagnostic sensitivity of hepatocellular carcinoma imaging and its application to non-cirrhotic patients. J Gastroenterol Hepatol. 26(4):745-750, 2011.

319.

Kuo Y.R.*, Chen C.C., Shih H.S., Goto S., Huang C.W., Wang C.T., Chen C.L., Wei F.C.: Prolongation of composite tissue allotransplant survival by treatment with bone marrow mesenchymal stem cells is correlated with T-cell regulation in a swine hind-limb model. Plast Reconstr Surg. 127(2):569-579, 2011.

318.

Chen K.D., Hsu L.W., Goto S., Yeh C.W., Nakano T., Lai C.Y., Chang Y.C., Hou C.H., Wang C.C., Cheng Y.F., Chiu K.W., Lin C.C., Chen C.L.*: Adaptor protein Shc acts as an immune-regulator for the LPS-stimulated maturation of bone marrow-derived dendritic cells. BMC Immunol. 12(1):32, 2011.

317.

Nakano T., Cheng Y.F., Lai C.Y., Hsu L.W., Chang Y.C., Deng J.Y., Huang Y.Z., Honda H., Chen K.D., Wang C.C., Chiu K.W., Jawan B., Eng H.L., Goto S., Chen C.L.*: Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. J Hepatol. 55(2):415-425, 2011.

316.

Sun C.K., Chen C.L.*, Concejero A.M., Wang C.C., Wang S.H., Liu Y.W., Yang C.H., Yong C.C.: Liver transplantation for primary biliary cirrhosis in a hepatitis endemic region: a single-center Asian experience. Clinical Transplant. 25(1): 47-53, 2011.

315.

Ou H.Y., Concejero A.M., Huang T.L., Chen T.Y., Tsang L.L., Chen C.L., Yu P.C., Yu C.Y., Cheng Y.F.*: Portal vein thrombosis in biliary atresia patients after living donor liver transplantation. Surgery. 149(1): 40-47, 2011.

314.

Chou M.H., Chuang J.H., Eng H.L., Chen C.M., Wang C.H., Chen C.L., Lin T.M. * Endotoxin and CD14 in the progression of biliary atresia. J Transl Med. 8:138, 2010.

313.

Chiou S.R., Lin T.L., Bora D., Lu H.I. , Chen C.L. , Wang S.H., Lin C.C. , Liu Y.W., Yong C.C., Li W.F., Liu C.Y., Wang C.C. * Metastatic Hepatocellular Carcinoma Mimicking a Solitary Mediastinal Tumor. J. Cancer 26(6):257-262, 2010.

312.

Chiu K.W., Tai W.C., Nakano T., Tseng H.P., Cheng Y.F., Jawan B., Goto S., Chen C.L.* Donor graft does not affect the P450 2C19 genotype expressed in peripheral blood in recipients of living donor liver transplantation. Clin Transplant. 24(6): 830-834, 2010.

311.

Liu C.Y., Yong C.C., Wu S.C., Lin C.Y., Chen C.L., Wang C.C.*: Sister Mary Joseph’s nodule associated with hepatocellular carcinoma. Surgery. 147(1): 167-8, 2010.

310.

Wang C.C.*, Jawade K., Yap A.Q., Concejero A.M., Lin C.Y., Chen C.L.: Resection of large hepatocellular carcinoma using the combination of liver hanging maneuver and anterior approach. World J Surg. 34(8): 1874-8, 2010.

309.

Chen H.L., Chen C.L., Huang T.L., Chen T.Y., Tsang L.L., Ou H.Y., Yu C.Y., Cheng Y.F.*: Regeneration rate of left liver grafts in adult living donor liver transplant. Transplant Proc. 42(3): 699-700, 2010.

308.

Chen J.P., Jawan B., Chen C.L., Wang C.H., Cheng K.W., Wang C.C., Concejero A.M., Villagomeza E., Huang C.J.*: Comparison of postoperative morphine requirements in healthy living liver donors, patients with hepatocellular carcinoma undergoing partial hepatectomy, and liver transplant recipients. Transplant Proc. 42(3): 701-2, 2010.

307.

Cheng K.W., Wang C.H., Chen C.L., Jawan B., Wang C.C., Concejero A.M., Wang S.H., Liu Y.W., Yong C.C., Yang C.H., Huang C.J.*: Decreased fresh gas flow cannot compensate for an increased operating room temperature in maintaining body temperature during donor hepatectomy for living liver donor hepatectomy. Transplant Proc. 42(3): 703-4, 2010.

306.

Hsu N.W., Chuang F.R., Chen Y.T., Chen C.L., Cheng Y.F.*: Hepatocellular carcinoma in kidney transplant recipients. Transplant Proc. 42(3): 811-3, 2010.

305.

Lu C.H., Chen C.L., Cheng Y.F., Huang T.L., Tsang L.L., Ou H.Y., Chen T.Y.*: Correlation between imaging and pathologic findings in explanted livers of hepatocellular carcinoma cases. Transplant Proc. 42(3): 830-3, 2010.

304.

Shih T.H., Chen K.H., Pao Y.Y., Yang S.C., Chen C.L., Huang C.J., Wang C.H.*, Jawan B., Cheng K.W., Yang C.H.: Low-dose dantrolene is effective in treating hyperthermia and hypercapnia, and seems not to affect recovery of the allograft after liver transplantation: case report. Transplant Proc. 42(3): 858-60, 2010.

303.

Lee W.F., Wu S.C., Yong C.C., Chen C.L., Wang C.C.*: Hand-assisted laparoscopic splenectomy--preliminary experience in southern Taiwan. Chang Gung Med J. 33(1): 67-72, 2010.

302.

Ou H.Y., Huang T.L., Chen T.Y., Tsang L.L., Chen C.L., Cheng Y.F.*: Early modulation of portal graft inflow in adult living donor liver transplant recipients with high portal inflow detected by intraoperative color Doppler ultrasound. Transplant Proc. 42(3): 876-8, 2010.

301.

Huang T.L., Cheng Y.F.*, Chen T.Y., Tsang L.L., Ou H.Y., Yu C.Y., Wang C.C., Wang S.H., Lin C.L., Cheung H.K., Eng H.L., Jawan B., Concejero A.M., Chen C.L.: Doppler ultrasound evaluation of postoperative portal vein stenosis in adult living donor liver transplantation. Transplant Proc. 42(3): 879-81, 2010.

300.

Chen T.Y., Chen C.L., Huang T.L., Tsang L.L., Ou H.Y., Yu C.Y., Lu C.H., Cheng Y.F.*: Does hepatic graft weight affect the reduction of spleen size after living donor liver transplantation? Transplant Proc. 42(3): 882-3, 2010.

299.

Huang C.J., Chen C.L., Goto S., Lai C.Y., Kao Y.S., Wang C.H., Eng H.L., Concejero A.M., Wang C.C., Cheng Y.F., Cheng K.W., Nakano T., Jawan B.*: Effects of hemorrhagic shock in early and late partial posthepatectomy rats. Transplant Proc. 42(3): 980-2, 2010.

298.

Chiu K.W., Nakano T., Hu T.H., Tseng H.P., Cheng Y.F., Jawan B., Eng H.L., Goto S., Chen C.L. Influence of CYP2C19 genotypes on graft pathological findings and postoperative liver function in recipients after living-donor liver transplantation. Ann Transplant. 15(4):38-43, 2010.

297.

Concejero A.M., Chen C.L.*: Reply: Ethical perspectives on living donor organ transplantation in Asia. Liver Transpl. 16(7):917, 2010.

296.

Cheng Y.F., Ou H.Y., Tsang L.L., Yu C.Y., Huang T.L., Chen T.Y., Concejero A.M., Wang C.C.,Wang S.H., Lin T.S., Liu Y.W., Yang C.H.,Yong C.C., Chiu K.W., Bruno Jawan, Eng H.L., Chen C.L. *:Vascular stents in the management of portal venous complications in living donor liver transplantation. Am J Transplant. 10(5):1276-1283, 2010.

295.

Kao Y.H., Chen C.L., Jawan B, Chung Y.H., Sun C.K., Kuo S.M., Hu T.H., Lin Y.C., Chan H.H.,Cheng K.H., Wu D.C., Goto S., Cheng Y.F., Chao D., Tai M.H.*: Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesis. J Hepatol. 52(1):96-105, 2010.

294.

Chen C.L.*, Concejero A.M.: Liver transplantation for hepatocellular carcinoma in the world: the Taiwan experience. J Hepatobiliary Pancreat Sci. 17(5):555-558, 2010.

293.

Nakano T., Goto S., Lai C.Y., Hsu L.W., Takaoka Y., Kawamoto S., Chiang K.C., Shimada Y., Ohmori N., Goto T., Sato S., Ono K., Cheng Y.F., Chen C.L.*: Immunological aspects and therapeutic significance of an autoantibody against histone H1 in a rat model of concanavalin A-induced hepatitis. Immunology. 129(4):547-555, 2010.

292.

Concejero A.M., Yong C.C., Chen C.L.*, Lu H.I., Wang C.C., Wang S.H., Liu Y.W., Yang C.H., Cheng Y.F., Jawan B.: Solitary pulmonary nodule in the liver transplant candidate: Importance of diagnosis and treatment. Liver Transplant. 16 (6): 760-766, 2010.

291.

Lin L.M., Lin C.C., Lam H.D., Chen C.L.*: Increasing the Participation of Intensive Care Unit Nurses to Promote Deceased Donor Organ Donation. Transplant Proc. 42: 716-718, 2010.

290.

Kao Y.H., Jawan B., Goto S., Pan M.C., Lin Y.C., Sun C.K., Hsu L.W., Tai M.H., Cheng Y.F., Nakano T., Wang C.S., Huang C.J., and Chen C.L.*: High concentration of magnolol induces hepatotoxicity under serum-reduced conditions. Phytomedicine. 17:469-474, 2010.

289.

Kuo Y.H., Lu S.N., Chen C.L., Cheng Y.F., Lin C.Y., Hung C.H., Chen C.H., Changchien C.S., Hsu H.C., Hu T.H., Lee C.M., Wang J.H.*: Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis. Eur J Cancer. 46:744-751, 2010.

288.

Yu C.Y., Chen C.L., Huang T.L., Chen T.Y., Tsang L.L., Ou H.Y., Concejero A.M., Wang C.C., Wang S.H., Cheng Y.F.: Preoperative imaging evaluation of the hepatic vasculature in biliary atresia patients undergoing LDLT: Comparison of MDCT and MRI. Pediatr Transplant. 13 (8): 984-989, 2009.

287.

Wang C.C., Iyer S.G., Low J.K., Lin C.Y., Wang S.H., Lu S.N., Chen C.L.* Perioperative factors affecting long-term outcomes of 473 consecutive patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg Oncol.16: 1832-1842, 2009.

286.

Lin T.S., Concejero A.M., Chen C.L.*, Chiang Y.C., Wang C.C., Wang S.H., Liu Y.W., Yang C.H., Yong C.C., Jawan B., Cheng Y.F. Routine microsurgical Biliary reconstruction decreases early anastomotic complications in living donor liver transplantation. Liver Transplant. 15: 1766-1775, 2009.

285.

Concejero A.M., Chen C.L.*: Ethical perspectives on living donor organ transplantation in Asia. LiverTransplant. 15:1658-1661, 2009.

284.

Chen C.L.*, Concejero A.M., Wang C.C., Wang S.H., Liu Y.W., Yang C.H., Yong C.C., Lin T.S.: Inferior vena cava replacement in living donor liver transplantation for hepatocellular carcinoma. Liver Transplant. 15: 1637-1640, 2009.

283.

Lin T.S., Chiang Y.C., Chen C.L.*, Concejero A.M., Cheng Y.F., Wang C.C., Wang S.H., Liu Y.W., Yang C.H., Yong C.C.: Intimal Dissection of the hepatic artery following trans-arterial embolization for hepatocellular carcinoma: an intra-operative problem in adult LDLT. Liver Transplant.15: 1553-1556, 2009.

282.

Kao Y.H., Jawan B., Goto S., Pan M.C., Lin Y.C., Sun C.K., Hsu L.W., Tai M.H., Cheng Y.F., Nakano T., Wang C.S., Huang C.J., and Chen C.L.*: Serum factors potentiate hypoxia-induced hepatotoxicity in vitro through increasing transforming growth factor-beta1 activation and release. Cytokine. 47:11-22, 2009.

281.

Chiu N.M.*, Chen C.L., Cheng Andrew T.A.: Psychiatric consultation for post liver transplantation patients. Psychiatry Clin Neurosci. 63: 471-477, 2009.

280.

Kuo Y.R.*, Shih H.S., Lin C.C., Huang C.C., Yang C.S.J., Wu W.S., Goto S., Chen C.L., Lee A.W.P.: Swine Hemi-Facial Composite Tissue Allotransplantation: A model to study immune rejection. J Surg Res. 153: 268-273, 2009.

279.

Huang Y.H., Chuang J.H.*, Huang C.C., Wu C.L., Chen C.L.: Cholestasis downregulate hepcidin expression through inhibiting IL-6-induced phosphorylation of signal transducer and activator of transcription 3 signaling. Lab Invest. 89:1128-1139, 2009.

278.

Chou C.Y., Chen Y.C.,Chen C.L., Chen J.L., Mu P.F.*: Family experience of waiting for living donor liver transplantation: from parental donor perspective. J Clin Nurs. 18:1684-1692, 2009.

277.

Kuo Y.R.*, Huang C.W, Goto S., Wang C.T., Hsu L.W., Lin Y.C., Yang K.D., Chen C.L., Lee A.: Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation. J Surg Res.153: 317-325, 2009.

276.

Kuo Y.R.*, Goto S., Shih H.S., Wang F.S., Lin C.C., Wang C.T., Huang E.Y., Chen C.L., Wei F.C., Zheng X.X., Lee W.P.: Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model. Transplantation 87: 1769-1777, 2009.

275.

Cheng Y.F., Ou H.Y. Tsang L.L., Yu C.Y., Huang T.L., Chen T.Y., Concejero A.M., Yong C.C., Chen C.L.*: Interventional percutaneous trans-splenic approach in the management of portal venous occlusion after living donor liver transplantation. Liver Transplant. 15:1378-1380, 2009.

274.

Cheng Y.F., Huang T.L., Chen T.Y., Tsang L.L., Ou H.Y., Yu C.Y., Concejero A.M., Wang C.C., Wang S.H., Lin T.S., Liu Y.W., Yang C.H., Yong C.C., Chiu K.W., Jawan B., Eng H.L. and Chen C.L.*:Liver Graft Regeneration in Right Lobe Adult Living Donor Liver Transplantation. Am J Transplant 9: 1382–1388, 2009.

273.

Chiang K.C., Shimada Y., Nakano T., Lai C.Y., Hsu L.W., Goto S., Ohmori N., Mori K., Miyagi T., Seiji Kawamoto S., Ono K., Chen C.L., Goto T.*, and Sato S.: A Novel Peptide Mimotope Identified as a Potential Immunosuppressive Vaccine for Organ Transplantation. J Immunol. 182: 4282–4288, 2009.

272.

Yang C.H., Chen C.L.*, Wang C.C., Concejero A.M., Wang S.H. Liu Y.W., Yong C.C., Lin T.S.: Dual grafts in adult-to-adult living donor liver transplantation: A single center experience in Taiwan. Surgery. 145:212-218, 2009.

271.

Kee K.M., Lin C.Y., Wang J.H., Lee C.M., Chen C.L., Changchien C.S., Hu T. H., Cheng Y.F., Hsu H.C., Wang C.C., Chen T.Y., Lu S.N.*: Is the cancer of the liver Italian program system an adequate weighting for survival of hepatocellular carcinoma? Evaluation of intrascore prognostic value among 36 subgroups. Liver Int. 74-81, 2009.

270.

Concejero A.M., Chen C.L.*, Chen T.Y., Eng H.L. Kuo F.Y.: Giant cavernous hemangioma of the liver with coagulopathy: Adult Kasabach-Merritt syndrome. Surgery. 145: 245-247, 2009.

269.

Wang C.C., Lin T.S., Chen C.L.*, Concejero A.M., Iyer S.G., Chiang Y.C.: Arterial reconstruction in hepatic artery occlusions in adult living donor liver transplantation using gastric vessels. Surgery. 143(5):686-690, 2008.

268.

Chen T.Y.,Chen C.L., Tsang L.L., Huang T.L., Wang C.C., Concejero A.M., Lu C.H., Cheng Y.F.*: Correlation between hepatic steatosis, hepatic volume, and spleen volume in live liver donors. Transplant Proc. 40:2481-2483, 2008.

267.

Huang Y.H., Huang C.C., Chuang J.H.*, Hsieh C.S., Lee S.Y., Chen C.L.: Upstream stimulatory factor 2 is implicated in the progression of biliary atresia by regulation of hepcidin expression. J Pediatr Surg. 43:2016-2023, 2008.

266.

Hsieh C.S., Huang L.T., Lee S.Y., Huang C.C., Lee C.L., Chuang J.H.*, Chen C.L.: Evaluation of hepatocyte growth factor in patients with biliary atresia. J Pediatr Surg. 43:1333-1337, 2008.

265.

Chen T.Y., Chen C.L., Huang T.L., Tsang L.L., Wang C.C., Liu Y.W., Yang C.C., Concejero A.M., Cheng Y.F.: Spleen volume and platelet count changes among donors after living donor liver transplantation. Hepatogastroenterology. 55:1211-1215, 2008.

264.

Yu C.Y., Concejero A.M., Huang T.L., Chen T.Y., Tsang L.L., Wang C.C., Wang S.H., Chen C.L., Cheng Y.F.*: Preoperative vascular evaluation in living donor liver transplantation for biliary atresia. Transplant Proc. 40:2478-2480, 2008.

263.

Tiao M.M., Yang C.Y., Tsai S.S., Chen C.L., Kuo H.W.*: Liver transplantation for biliary atresia in Taiwan: a national study. Transplant Proc. 40: 3569-3570, 2008.

262.

Tsang L.L., Chen C.L., Huang T.L., Chen T.Y., Wang C.C., Ou H.Y., Lin L.H., Cheng Y.F.*: Preoperative imaging evaluation of potential living liver donors: reasons for exclusion from donation in adult living donor liver transplantation. Transplant Proc. 40:2460-2462, 2008.

261.

Sun C.K., Chen C.L.*, Concejero A.M., Wang C.C., Wang S.H., Liu Y.W., Yang C.H., Yong C.C.: Retransplantation for end-stage liver disease: a single-center Asian experience. Transplant Proc. 40:2503-2506, 2008.

260.

Chen H.L., Concejero A.M., Huang T.L., Chen T.Y., Tsang L.L., Wang C.C., Wang S.H., Chen C.L., Cheng Y.F.*: Diagnosis and interventional radiological treatment of vascular and biliary complications after liver transplantation in children with biliary atresia. Transplant Proc. 40:2534-2536, 2008.

259.

Wang C.S., Chen C.L., Huang C.J., Cheng K.W., Chen K.H., Wang C.C., Concejero A.M., Cheng Y.F., Huang T.L., Wang S.H., Lin C.C., Liu Y.W., Yong C.C., Yang C.H., Jawan B.*: Effects of different operating room temperatures on the body temperature undergoing live liver donor hepatectomy. Transplant Proc. 40:2463-2465, 2008.

258.

Wang C.H., Chen C.L., Cheng K.W., Huang C.J., Chen K.H., Wang C.C., Concejero A.M., Cheng Y.F., Huang T.L., Chiu K.W., Wang S.H., Lin C.C., Liu Y.W., Jawan B.*: Bispectral index monitoring in healthy, cirrhotic, and end-stage liver disease patients undergoing hepatic operation. Transplant Proc. 40: 2489-2491, 2008.

257.

Huang C.J., Chen C.L., Wang C.S., Cheng K.W., Chen K.H., Wang C.C., Concejero A.M., Cheng Y.F., Huang T.L., Chiu K.W., Wang S.H., Lin C.C., Liu Y.W., Jawan B.*: Rhabdomyolysis after liver transplantation: a case report. Transplant Proc. 40: 2821-2822, 2008.

256.

Cheng K.W., Chen C.L., Wang C.S., Huang C.J., Chen K.H., Wang C.C., Concejero A.M., Cheng Y.F., Huang T.L., Chiu K.W., Wang S.H., Lin C.C., Liu Y.W., Jawan B.*: Anesthesia management in a patient with an abodominal aortic aneurysm undergoing liver transplantation: a case report. Transplant Proc. 40:2830-2831, 2008.

255.

Yamanaka Y., Kawamoto S., Katayama A., Kiso T., Aki T., Nakano T., Ohmori N., Goto T., Sato S., Chiang J., Shimada Y., Goto S., Chen C.L., Ono K.*: Anti-histone H1 autoantibody directly acts on T cells to exert its immunosuppressive activity. Animal Cell Technology: Basic & Applied Aspects. 15: 153-158, 2008.

254.

Katayama A., Kawamoto S., Yamanaka Y., Kiso T., Aki T., Nakano T., Ohmori N., Goto T., Sato S., Chiang J., Shimada Y., Goto S., Chen C.L., Ono K*.: Anti-histone H1 autoantibody: An inducible immunosuppressive factor in liver transplantation. Animal Cell Technology: Basic & Applied Aspects. 15: 145-151, 2008.

253.

Lee C.H., Chen C.L., Lin C.C., Yang C.H., Cheng Y.F., Wang M.C., Eng H.L., Liu P.P., Chuang F.R.*: Plasma exchange therapy for thrombotic thrombocytopenic purpura in pediatric patients with liver transplantation. Transplant Proc. 40: 2554-2556, 2008.

252.

Nakano T., Lai C.Y., Goto S., Hsu L.W., Huang T.L., Chen T.Y., Tsang L.C., Chen C.L., Cheng Y.F.*: Significance of portosystemic shunt on graft survival in liver transplantation: a rat model. Transplant Proc. 40:2515-2516, 2008.

251.

Kao Y.H., Jawan B., Goto S., Hung C.T., Lin Y.C., Nakano T., Hsu L.W., Lai C.Y., Tai M.H., Chen C.L.* : High-Mobility Group Box 1 Protein Activates Hepatic Stellate Cells In Vitro. Transplant Proc. 40:2704-2705, 2008.

250.

Lin Y.C., Goto S., Tateno C., Kao Y.H., Cheng Y.F., Jawan B., Nakano T., Hsu L.W., Lai C.Y., Yoshizato K., Chen C.L.*: Induction of indoleamine 2,3-dioxygenase in livers following hepatectomy prolongs survival of allogeneic hepatocytes after transplantation. Transplant Proc. 40:2706-2708, 2008.

249.

Wang C.H., Goto S., Chen C.L., Lai C.Y., Kao Y.S., Lin Y.C., Eng H.L., Huang C.J., Chen K.H., Wang C.C., Cheng Y.F., Jawan B.*: The reaction of posttransplant denervated liver on the hemorrhagic shock in rats. Transplant Proc. 40:2175-2177, 2008.

248.

Lin Y.C.*, Chen C.L., Nakano T., Goto S., Kao Y.H., Hsu L.W., Lai C.Y., Jawan B., Cheng Y.F., Tateno C., Yoshizato K.: The immunological role of indoleamine 2,3-dioxygenase in rat liver allograft rejection and tolerance. J Gastroenterol Hepatol. 23: e243-50, 2008.

247.

Jawan B., Kao Y.H, Goto S., Pan M.C., Lin Y.C. , Hsu L.W. , Nakano T. , Lai C.Y., Sun C.K. , Cheng Y.F. , Tai M.H., Eng H.L., Wang C.S. , Huang C.J., Chen C.L.*: Propofol pretreatment attenuates LPS-induced granulocyte-macrophage colony-stimulating factor production in cultured hepatocytes by suppressing MAPK/ERK activity and NF-kappaB translocation. Toxicol Appl Pharmacol. 229: 362-373, 2008.

246.

Nakano T., Goto S., Lai C.Y., Hsu L.W., Wong J.L., Kawamoto S., Chiang K.C., Ohmori N., Goto T., Sato S., Yang C.H., Wang C.C., Jawan B., Cheng Y.F., Ono K., Chen C.L.*: Involvement of autoimmunity against nuclear histone H1 in liver transplantation tolerance. Transpl Immunol. 19(2): 87-92, 2008.

245.

Hsu, L.W., Chen, C.L., Nakano, T., Lai, C.Y., Chiang, K.C., Yang, C.H., Lin, Y.C., Kao, Y.H., Chen, S.H., Goto, T., Sung, W.C., Cheng, Y.F., Jawan, B., Chiu, K.W., Goto, S.*: The role of a nuclear protein, histone H1 on signaling pathways for the maturation of dendritic cells. Clin Exp Immunol. 52(3): 576-84, 2008.

244.

Concejero A.M., Chen C.L.*, Wang C.C., Wang S.H., Lin C.C., Liu Y.W., Yang C.C., Yong C.C., Lin T.S., Jawan B., Huang T.L., Cheng Y.F., Eng H.L.: Living donor liver transplantation for hepatocellular carcinoma: A single-center experience in Taiwan. Transplantation. 85: 398-406, 2008.

243.

Wang J.H., Changchien C.S., Hu T.H., Lee C.M., Kee K.M.,Lin C.Y., Chen C.L., Chen T.Y., Huang Y.J., Lu S.N.*: The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients. Eur J Cancer. 44: 1000-1006, 2008.

242.

Yin C.H., Chenb W., Hsiao C.C.*, Chen C.L., Wu W.T.*: Improving albumin production of hepatic lineage cells from mouse embryonic stem cells in vitro. Biochem Eng J. 39: 435-442, 2008.

241.

Changchien C.S., Chen C.L., Yen Y.H., Wang J.H., Hu T.H., Lee C.M., Wang C.C., Cheng Y.F. Huang Y.J., Lin C.Y., Lu S.N.*: Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival. J Gastroenterol. 43:159-170, 2008.

240.

Yong C.C., Concejero A.M., Ibrahim S., Fernandes E., Chen T.Y., Chen C.L., Wang C.C.*: Pancreatico-duodenectomy and portal vein repair in blunt abdominal trauma. J Trauma. 64(1): E4-7, 2008.

239.

Concejero A.M., Chen C.L.*, Liang C.D., Wang C.C., Wang S.H., Lin C.C., Liu Y.W., Yong C.C., Yang C.H., Jawan B., Cheng Y.F.: Atrial septal defect in end-stage liver disease children before and after liver transplantation. Surgery. 143(2): 271-277, 2008.

238.

Wang S.H., Concejero A.M., Chen C.L.*, Wang C.C., Lin C.C., Liu Y.W., Yang C.H., Yong C.C.: A simple and inexpensive technique of upper abdominal wall retraction in pediatric liver surgery and transplantation. Pediatr Transplant. 12: 150-152, 2008.

237.

Tiao M.M., Tsai S.S. Kuo H.W., Chen C.L., Yang C.Y.*: Epidemiological features of biliary atresia in Taiwan, a national study 1996-2003. J Gastroenterol Hepatol. 23(1):62-66, 2008.

236.

Shimada Y., Goto T.*, Kawamoto S., Kiso T., Katayama A., Yamanaka Y., Aki T., Chiang K.C., Nakano T., Goto S., Chen C.L., Ohmori N., Ono K., Sato S.: Development of a two-step chromatography procedure that allows the purification of a high-purity anti-histone H1 monoclonal immunoglobulin M antibody with immunosuppressant activity. Biomed Chromatogr. 22:13-19, 2008.

235.

Kao Y.H., Goto S., Jawan B., Nakano T., Hsu L.W., Lin Y.C., Pan M.C., Lai C.Y., Sun C.K., Cheng Y.F., Tai M.H., Huang H.T., Chen C.L.*: Heat preconditioning ameliorates hepatocyte viability after cold preservation and rewarming, and modulates its immunoactivity. Transpl Immunol. 18:220-231, 2008.

234.

Tiao M.M., Lin T.K., Kuo F.Y., Huang C.C., Du Y.Y., Chen C.L., Chuang J.H.*: Early stage of biliary atresia is associated with significant changes in 8-hydroxydeoxyguanosine and mitochondrial copy number. J Pediatr Gastroenterol Nutr. 45(3):329-334, 2007.

233.

Tiao M.M., Lu L., Huang L.T., Liang C.D., Chen C.L., Tao R., Fung J.J., Qian S.* : Cross-tolerance if recipient-derived transforming growth factor-beta dendritic cells. Transplant Proc. 39(1): 281-2, 2007.

232.

Hu T.H., Wang C.C., Huang C.C., Chen C.L., Hung C.H., Chen C.H., Wang J.H., Lu S.N., Lee C.M., Changchien C.S., Tai M.H.*: Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection. Oncol Rep. 18:1417-1426, 2007.

231.

Hsu L.W., Yang C.H., Goto S., Nakano T., Lai C.Y., Lin Y.C., Kao Y.H., Chen S.H., Cheng Y.F., Jawan B., Chiu K.W., Chen C.L.*: The effects of suplatast tosilate (IPD-1151T) on innate immunity and antigen presenting cells. Transpl Immunol. 18: 108-114, 2007.

230.

Hung K.C., Yong C.C., Chen Y.S., Eng H.L., Kuo F.Y., Lin C.C., Young T.H., Kobayashi E., Chen C.L., Wang C.C.*:A surgical model of fulminant heptic failure in rabbits. Liver Int. 27(10):1333-1341, 2007.

229.

Liu Y.W., Concejero A.M., Chen C.L.*, Cheng Y.F., Eng H.L., Huang T.L., Chen T.Y., Wang C.C., Wang S.H., Lin C.C., Yong C.C., Yang C.H., Jordan A.P., Jawan B.: Hepatic pseudotumor in long-standing biliary atresia patients undergoing liver transplantation. Liver Transpl. 13: 1545-1551, 2007.

228.

Chen C.L.*, Concejero A.M., Wang C.C., Wang S.H., Liu Y.W., Yong C.C., Yang C.H., Jordan A., Cheng Y.F.: Remodeled saphenous vein as interposition graft for portal vein reconstruction in living donor liver transplantation. Liver transpl. 13: 1472-1475, 2007.

227.

Kao J.T., Chuah S.K., Huang C.C., Chen C.L., Wang C.C. Hung C.H., Chen C.H., Wang J.H., Lu S.N., Lee C.M., Changchien C.S., Hu T.H.*: P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection. Liver Int.6: 772-781, 2007.

226.

Concejero A.M., Chen C.L.*, Liang C.D., Wang C.C., Wang S.H., Lin C.C., Liu Y.W., Yong C.C., Yang C.H., Lin T.S., Jawan B., Huang T.L., Cheng Y.F., Eng H.L.: Living donor liver transplantation in children with congenital heart disease. Transplantation .84:484-489, 2007.

225.

Chen C.L.* and Concejero A.M.: Early post-operative complications in living donor liver transplantation: prevention, detection and management (Editorial). Hepatobiliary Pancreat Dis Int. 6: 345-347, 2007.

224.

Lin C.C., Chen C.L.*, de Villa V.H., Chen Y.S., Wang C.C., Wang S.H., Cheng Y.H., Huang T.L.: Living donor hepatectomy in a pregnant woman. Hepatogastroenterology. 54: 539-40, 2007.

223.

Liang C.D., Ko S.F., Chen C.L.*, Concejero A.M.: Impact of mild and moderate intrapulmonary shunting in children with end-stage liver disease undergoing liver transplantation. World J Surg. 31: 1474-1479, 2007.

222.

Iyer S., Chen C.L.*, Wang C.C., Wang S.H., Liu Y.W., Yang C.H., Yong C.C., Concejero A., Jawan B., Cheng Y.F., Eng H.L.: Long-Term Results of Living Donor Liver Transplantation for Glycogen Storage Disorders in Children. Liver transpl. 13: 848-852, 2007.

221.

Concejero A., Chen C.L.*, Wang M.C., Eng H.L., Wang C.C., Wang S.H., Lin C.C., Liu Y.W., Yang C.H., Yong C.C.: Chronic myeloid leukemia after living donor liver transplantation. Transplantation. 83: 1521-1522, 2007.

220.

Nakano T., Goto S., Lai C.Y., Hsu L.W., Kao Y.H., Lin Y.C., Kawamoto S., Chiang K.C., Ohmori N., Goto T., Sato S., Jawan B., Cheng Y.F., Ono K., Chen C.L.*: Experimental and clinical significance of antinuclear antibodies in liver transplantation. Transplantation. 83: 1122-1125, 2007.

219.

Kee K.M., Wang J.H., Lee C.M., Chen C.L., Changchien C.S., Hu T.H., Cheng Y.F., Hsu H.C., Wang C.C., Chen T.Y., Lin C.Y., Lu S.N.*: Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: Analysis of 5,613 cases from a medical center in southern Taiwan. Int J Cancer. 120: 2650-2655, 2007.

218.

Tiao M.M., Chuang J.H., Huang L.T., Hsieh C.S.*, Lee S.Y., Liang C.D., Chen C.L.: Management of Biliary Atresia: Experience in a Single Institute. Chang Gung Med J. 30:122-127, 2007.

217.

Yin C.H., Chen W., Hsiao C.C.*, Kuo C.Y., Chen C.L., Wu W.T.: Production of mouse embryoid bodies with hepatic differentiation potential by stirred tank bioreactor. Biosci Biotechnol Biochem. 71: 728-734, 2007.

216.

Nakano T., Goto S., Lai C.Y., Hsu L.W., Ono K., Kawamoto S., Lin Y.C., Kao Y.H., Chiang K.C., Ohmori N., Goto T., Sato S., Tu C.H., Jawan B., Cheng Y.F., Chen C.L.*: Impact of vaccine therapy using nuclear histone H1 on allograft survival in experimental organ transplantation. Transpl Immunol. 17: 147-152, 2007.

215.

Wang S.H., Chen C.L.*, Concejero A.M., Wang C.C., Lin C.C., Liu Y.W., Yong C.C., Yang C.H., Lin T.S., Chiang Y.C., Jawan B., Huang T.L., Cheng Y.F., Eng H.L.: Living donor liver transplantation for biliary atresia. Chang Gung Med J. 30: 103-108, 2007.

214.

Nakano T., Chen C.L., Goto S., Lai C.Y., Hsu L.W., Kawamoto S., Sasaki T., Lin Y.C., Kao Y.H., Ohmori N., Goto T., Sato S., Jawan B., Ono K., and Cheng Y.F.*: The immunological role of lipid transfer/metabolic proteins in liver transplantation tolerance. Transpl Immunol. 17: 130-136, 2007.

213.

Hsu L.W., Goto S., Nakano T., Lai C.Y., Lin Y.C., Kao Y.H., Chen S.H., Cheng Y.F., Jawan B., Chiu K.W., Chen C.L.*: Immunosuppressive activity of serum taken from a liver transplant recipient after withdrawal of immunosuppressants. Transpl Immunol. 17: 137-146, 2007.

212.

Huang Y.H., Chou M.H., Du Y.Y., Huang C.C., Wu C.L., Chen C.L., Chuang J.H.*: Expression of toll-like receptors and type 1 interferon specific protein MxA in biliary atresia. Lab Invest. 87:66-74, 2007.

211.

Ibrahim S., Chen C.L.*, Wang S.H., Lin C.C., Yang C.H., Yong C.C., Jawan B., Cheng Y.F.: Liver resection for benign liver tumors: indications and outcome. Am J Surg. 193: 5-9, 2007.

210.

Lin C.C., Chen C.L.*, Concejero A.M., Wang C.C., Wang S.H., Liu Y.W., Yang C.H., Yong C.C., Lin T.S., Jawan B., Cheng Y.F., Eng H.L.: Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients. Am J Transplant. 7: 195-200, 2007.

209.

Liu Y.W., Chen C.L.*, Chen Y.S., Wang C.C., Wang S.H., Lin C.C.: Needle tract implantation of hepatocellular carcinoma after fine needle biopsy. Dig Dis Sci. 52: 228-231, 2007.

208.

Chen T.Y., Chen C.L., Huang T.L., Tsang L.L., Wang C.C., Wang S.H., Yang C.H., Concejero A.M., Cheng Y.F.*: Remnant liver regeneration and spleen volume changes after living liver donation: influence of the middle hepatic vein. Clin Transplant. 20:725-731, 2006.

207.

Wang C.C., Lin C.C., Young T.H., Chen Y.S., Yong C.C., Kobayashi E., Wu C.H., Yang C.H., Chen C.L., Hung K.C.*: Culture and characterization of human hepatocytes isolated from hepatitis C virus infected liver: Effect of collagen-coated surface and FBS-supplemented medium. Biochem Eng J 29 (1-2): 149-156, 2006.

206.

Lin C.C., Hung K.C., Young T.H., Chen Y.S., Yong C.C., Kobayashi E., Wu C.H., Yang C.H., Chen C.L., Wang C.C.*: Influence of hypothermic conditions on primary porcine hepatocyte-entrapped hollow fiber bioreactors. Biochem Eng J 29: 139-148, 2006.

205.

Ibrahim S., Chen C.L.*, Wang C.C.,.Wang SH, Lin C.C., Liu Y.W., Yang C.H., Yong C.C., Concejero A.M., Cheng Y.F.: Small remnant liver volume after right lobe living donor hepatectomy. Surgery. 140: 749-755, 2006.

204.

Nakano T., Ono K., Goto S., Lai C.Y., Hsu L.W., Kawamoto S., Lin Y.C., Kao Y.H., Chiang K.C., Ohmori N., Goto T., Sato S., Jawan B., Cheng Y.F., Chen C.L.*: Histone H1 vaccine therapy for overcoming the acute rejection in experimental organ transplantation. Transplant Proc. 38:3247-3248, 2006.

203.

Nakano T., Lai C.Y., Goto S., Hsu L.W., Lin Y.C., Kao Y.H., Kawamoto S, Chiang K.C., Ohmori N., Goto T., Sato S., Ono K., Jawan B., Cheng Y.F., Chen C.L.*: Role of antinuclear antibodies in experimental and clinical liver transplantation. Transplant Proc 38:3605-3606, 2006.

202.

Cheng Y.F., Huang T.L., Chen T.Y., Concejero A.M., Tsang L.L., Wang C.C., Wang S.H., Sun C.K., Lin C.C., Liu Y.W., Yang C.H., Yong C.C., Ou S.Y., Yu C.Y., Vchiu K.W., Jawan B., Eng H.L., Chen C.L.*: Liver graft-to-recipient spleen size ratio as a novel predictor of portal hyperperfusion syndrome in living donor liver transplantation. Am J Transplant. 6:2994-2999, 2006.

201.

Takatsuki M., Chiang Y.C., Lin T.S., Wang C.C., Concejero A.M., Lin C.C., Huang T.L., Cheng Y.F., Chen C.L.*: Anatomical and aspects of hepatic artery reconstruction in living donor liver transplantation. Surgery. 140:824-828, 2006.

200.

Chen C.L.*, Concejero A.M., Wang C.C., Wang S.H., Lin C.C., Liu Y.W., Yong C.C., Yang C.H., Lin T.S., Chiang Y.C., Jawan B., Huang T.L., Cheng Y.F., Eng H.L.: Living donor liver transplantation for biliary atresia: a single center experience with first 100 cases. Am J Transplant. 6:2672-2679, 2006.

199.

Ibrahim S., Chen C.L.*, Lin C.C., Yang C.H., Wang C.C., Wang S.H., Liu Y.W., Yong C.C., Concejero A.M., Jawan B., Cheng Y.F.: Intraoperative blood loss is a risk factor for complications in donors after living donor hepatectomy. Liver transpl. 12:950-957, 2006.

198.

Huang Y.H., Yu-Hsieh H., Huang C.C., Tseng V.S.M., Tai M.H., Chen C.L., Chuang J.H.*: Liver hepcidin and stainable iron expression in biliary atresia. Pediat Res. 59:662-666, 2006.

197.

Liu J.W., Lu S.N., Chen S.S., Yang K.D., Lin M.C., Wu C.C., Bloland P.B., Park S.Y., Wong W., Tsao K.C., Lin T.Y. Chen C.L.*: Epidemiologic study and containment of a nosocomial outbreak of severe acute respiratory syndrome in a medical center in Kaohsiung, Taiwan. Infect Control Hosp Epidemiol 27:466-472, 2006.

196.

Lin C.C., Chen C.L.*, Cheng Y.F., Chiu K.W., Jawan B., Hsaio C.C.: Major hepatectomy in children-Approaching blood transfusion free. World J Surg 30:1115-1119, 2006.

195.

Concejero A.M., Chen C.L.*, Wang C.C., Wang S.H., Lin C.C., Liu Y.W., Yang C.H., Yong C.C., Lin T.S., Ibrahim S., Jawan B., Cheng Y.F., Huang T.L.: Donor graft outflow venoplasty in living donor liver transplantation. Liver Transpl. 12:264-268, 2006.

194.

Wang C.C., Concejero A.M., Yong C.C., Chen Y.S., Wang S.H., Lin C.C., Liu Y.W., Yang C.H., Lin T.S., Hung K.C., Jawan B., Cheng Y.F., Ibrahim S., Chen C.L.*: Improving hepatic and portal venous flows using tissue expander and foley catheter in liver transplantation. Clin Transpl. 10: 81-84, 2006.

193.

Lee C.M.*, Hung C.H., Lu S.N., Wang J.H., Tung H.D., Huang W.S., Chen C.L., Chen W.J., Changchien C.S.: Viral etiology of hepatocellular carcinoma and HCV genotypes in Taiwan. Intervirology 49:76-81, 2005.

192.

Lu S.N., Jiang D.D., Liu JW, Lin M.C., Chen C.L., Su I.J., Chen S.S.*: Outbreak of severe acute respiratory syndrome in southern Taiwan, 2003. Am J Trop Med Hyg 73:423-427,2005.

191.

Liu P.P.*, Chen C.L., Cheng Y.F., Hsieh P.M., Tan B.L., Jawan B., Ko S.F.: Use of a refined operative strategy in combination with the multidisciplinary approach to manage blunt juxtahepatic venous injuries. J Trauma. 59:940-945,2005.

190.

Hsieh C.S., Chuang J.H., Huang C.C., Chou M.H., Wu C.L., Lee S.Y. Chen C.L. : Evaluation of matrix metalloproteinases and their endogenous tissue inhibitors in biliary atresia-associated liver fibrosis. J Pediatr Surg 40: 1568-1573, 2005.

189.

Shih H.H., Lin T.M., Chuang J.H.*, Eng H.L., Juo S.H.H., Huang F.C., Chen C.L., Chen H.L.: Promoter polymorphism of the CD14 endotoxin receptor gene is associated with biliary atresia and idiopathic neonatal cholestasis. Pediatrics. 116:437-441, 2005.

188.

Wang C.C., Wang S.H., Lin C.C., Liu Y.W., Yong C.C., Yang C.H., Huang K.C., Lin T.S., Jawan B., Cheng Y.F., Eng H.L., Concejero A.M., Chen C.L.*: Liver Transplantation from an uncontrolled non-heart-beating donor maintained on extracorporeal membrane oxygenation. Transplant Proc. 37:4331-4333, 2005.

187.

Ibrahim S., Chen C.L.*, Wang C.C., Wang S.H., Lin C.C., Liu Y.W., Yang C.H., Yong C.C., Concejero A.M., Cheng Y.F.: Liver regeneration and splenic enlargement in donor after living-donor liver transplantation. World J Surg. 29:1658-1666, 2005.

186.

Lin C.C., Chuang F.R., Lee C.H., Wang C.C., Chen Y.S., Liu Y.W., Jawan B., Chen C.L.*: The renal-sparing efficacy of basiliximab in adult living donor liver transplantation. Liver Transpl. 10:1258-1264, 2005.

185.

Ou H.Y., Huang T.L., Chen T.Y., Tsang L.L., Concejero A.M., Chen C.L., Cheng Y.F.*: Emergency splenic arterial embolization for massive variceal bleeding in liver recipient with left-sided portal hypertension. Liver Transpl. 11: 1136-1139, 2005.

184.

Jawan B., Cheng Y.F., Tseng C.C., Chen Y.S., Wang C.C., Huang T.L., Eng H.L., Po-ping Liu, Chiu K.W., Wang S.H., Lin C.C., Lin T.S., Liu Y.W., Chen C.L.*: The effect of autologous blood donation on the central venous pressure, blood loss and blood transfusion during living donor left hepatectomy. World J Gastroenterol. 11:4233-4236, 2005.

183.

Huang C.C., Chuang J.H.*, Chou M.H., Wu C.L., Chen C.M., Wang C.C., Chen Y.S., Chen C.L., Tai M.H.: Matrilysin (MMP-7) is a major matrix metalloproteinase upregulated in biliary atresia-associated liver fibrosis. Mod Pathol. 18: 941-950, 2005.

182.

Jawan B., Tseng C.C., Chen Y.S., Wang C.C., Cheng Y.F.,Huang T.L., Eng H.L., King- K.W., Wang S.H., Lin C.C., Lin T.S., Liu Y.W. , Chen C.L.*: Is there any difference in anesthetic management of biliary atresia and glycogen storage disease patients undergoing liver transplantation? J Surg Res. 126(1): 82-85, 2005.

181.

Cheng K.W., Chen C.L., Cheng Y.F., Tseng C.C., Wang C.S., Chen Y.S., Wang C.C., Huang T.L., Eng H.L., Chiu K.W., Wang S.H., Lin C.C., Lin T.S., Liu Y.W., Jawan B.*: Dextrose in the banked blood products does not seem to affect the blood glucose levels in patients undergoing liver transplantation. World J Gastroenterol. 11(18): 2789-2791, 2005.

180.

Hsu L.W., Goto S., Nakano T., Lai C.Y., Kao Y.H., Lin Y.C., Kawamoto S., Ono K., Lord R., Goto T., Omori N., Sato S., Chiang K.C., Chen S.H., Jawan B., Cheng Y.F., Chiu K.W., Chen C.L.*: The effects of anti-histone H1 antibody on immune cells responsible for rejection reaction. Mol Immunol. 42:1155-1164, 2005.

179.

Cheng Y.F., Chen C.L.*, Huang T.L., Chen T.Y., Lee T.Y., Chen Y.S., Wang C.C., Eng H.L., Jawan B.: Angioplasty treatment of hepatic vein stenosis with segmental pediatric liver transplants: long-term results. Transpl Int. 18:556-561, 2005.

178.

Huang C.J., Chen C.L., Tseng C.C., Luk H.N., Villa V.D., Wang C.S., Chen Y.S., Wang C.C., Cheng Y.F., Huang T.L., Chiu K.W., Wang S.H., Lin C.C., Lin T.S., Liu Y.W., Jawan B.*: Maintenance of normothermia at operation room temperature of 24 degrees C in adult and pediatric patients undergoing liver transplantation. Transpl Int. 18:396-400, 2005.

177.

Cheng Y.F., Huang T.L., Chen T.Y., Lee T.Y., Chen Y.S., Wang C.C., Eng H.L., Jawan B., Chen C.L.*: Impact of pre-operative transarterial embolization on the treatment of hepatocellular carcinoma with liver transplantation. World J Gastroenterol. 11(10):1433-1438, 2005.

176.

Huang T.L., Chen T.Y., Tsang L.L., Weng H.H., Cheng Y.F.*, Chen Y.S., Wang C.C., Wang S.H., Lin T.S., Cheung H.K., Jawan B., Chen C.L.: The significance of hepatic vein outflow volume in hepatic outflow insufficiency of living right liver graft evaluated by Doppler ultrasound. Transplant Proc. 37:1115-1116, 2005.

175.

Nakano T., Kawamoto S., Lai C.Y., Hsu L.W., Lin Y.C., Sasaki T., Aki T., Shigeta S., Goto T., Ohmori N., Sato S., Goto S., Ono K., Chen C.L.*: Characterization of immunosuppressive factors expressed in serum by rat tolerogenic liver transplantation. Transplant Proc. 37:80-81, 2005.

174.

Lin C.C., Chen C.L.*, Cheng Y.F.: Modified extended distal pancreatectomy for carcinoma of body and tail of the pancreas. Hepatogastroenterology. 52: 1090-1091, 2005.

173.

Yong C.C, Chen Y.S., Wang S.H., Liu C.C., Liu P.P., Liu Y.W., Yang C.H., Hung K.C., Chiang Y.C., Lin T.S., Cheng Y.F., Huamg T.L., Bruno Jawan, Eng H.L., Chen C.L., Wang C.C.*: Deceased-Donor Liver Transplantation: 10 Years' Experience at Chang Gung Memorial Hospital-Kaohsiung Medical Center. Chang Gung Med J 28:133-141, 2005.

172.

Chiu K.W., Chen Y.S., de Villa V.H., Wang C.C., Eng H.L., Wang S.H., Liu P.P., Jawan B., Huang T.L., Cheng Y.F., Chen C.L.*: Characterization of liver enzymes on living related liver transplantation patients with acute rejection. Hepatogastroenterology. 52:1825-1827, 2005.

171.

Chiu Y.C., Wu K.L., Chou Y.P., Fon T.V., Tsai T.L., Kuo C.M., Kuo C.H., Chiu K.W., Liu J.W., Eng H.L., Jawan B., Cheng Y.F., Chen C.L.*: Diarrhea in medical care workers with severe acute respiratory syndrome. J Clin Gastroenterol. 38 : 880-882, 2004.

170.

Lee S.Y., Chuang J.H.*, Huang C.C., Chou M.H., Wu C.L., Chen C.M., Hsieh C.S., Chen C.L. Identification of transforming growth factors actively transcribed during the progress of liver fibrosis in biliary atresia. J Pediatr Surg. 39 : 702-708 ,2004.

169.

Jawan B.*, de Villa V., Luk H.N., Wang C.S., Huang C.J., Chen Y.S., Wang C.C., Cheng Y.F., Huang T.L., Eng H.L., Liu P.P., Chiu K.W., Chen C.L.: Perioperative normovolemic anemia is safe in pediatric living-donor liver transplantation. Transplantation. 77:1394-1398, 2004

168.

Huang T.L., Chen T.Y., Tsang L.L., Sun P.L., Chen Y.S., Wang C.C., Wang S.H., Lin T.S., Chiang Y.C., Chiu K.W., Eng H.L., Jawan B., Cheng Y.F.*, Chen C.L.: Hepatic venous stenosis in partial liver graft transplantation detected by color Doppler ultrasound before and after radiological interventional management. Transplant Proc. 36: 2342-2343, 2004.

167.

Lin C.C., Chuang F.R., Wang C.C., Chen Y.S., Chen C.L.*, Liu Y.W., Cheng Y.F., Lee C.H., Jawan B.: Early postoperative complications in recipients of living donor liver transplantation. Transplant Proc. 36: 2338-2341, 2004.

166.

Chuang F.R., Lin C.C., Wang P.H., Cheng Y.F., Hsu K.T., Chen Y.S., Lee C.H.*, Chen C.L.: Acute renal failure after cadaveric related liver transplantation. Transplant Proc. 36: 2328-2330, 2004.

165.

Sun P.L., Chen C.L., Hsu S.L., Huang T.L., Chen T.Y., Chen Y.S., Tsang L.C., Cheng Y.F.*: The significance of transarterial embolization for advanced hepatocellular carcinoma in liver transplantation. Transplant Proc. 36: 2295-2296, 2004.

164.

Wu W.H.*, Wan Y.L., Lee L., Yang Y.M., Huang Y.T., Chen C.L., Fan S.T.: First two cases of living related liver transplantation with complicated anatomy of blood vessels in Beijing. World J Gastroenterol. 10: 2854-2858, 2004.

163.

Chong M.Y.*, Wang W.C., Hsieh W.C., Lee C.Y., Chiu N.M., Yeh W.C., Huang T.L., Wen J.K., Chen C.L.: Psychological impact of severe acute respiratory syndrome on health workers in a tertiary hospital. Brit J Psychiat 185: 127-133, 2004.

162.

Cheng Y.F.*, Chen C.L., Huang T.L., Chen T.Y., Chen Y.S., Takatsuki M., Wang C.C., Chiu K.W., Tsang L.L., Sun P.L., Jawan B.: Risk factors for intraoperative portal vein thrombosis in pediatric living donor liver transplantation. Clin Transplant. 18: 390-394, 2004.

161.

Cheng Y.F., Chen C.L.*, Huang T.L., Chen T.Y., Chen Y.S., Wang C.C., Tsang L.L., Chiu K.W., Jawan B., Eng H.L.: 3DCT angiography for detection of vascular complications in pediatric liver transplantation. Liver Transpl. 10: 248-252, 2004.

160.

Takatsuki M., Chen C.L.*, Wang C.C., Lin C. C., Yang C. H., Yong C.C., Liu Y.W.: Impact of late conversion from C0 to C2 monitoring of microemulsified cyclosporine in pediatric living donor liver transplant recipients. Clin Transplant. 18: 694-699, 2004.

159.

Ko S.F.*, Lee T.Y., Huang C.C., Cheng Y.F., Ng S.H., Kuo Y.L.,Lin M.C., Liu J.W., Yang K.D., Chen M.C., Chen, C.L.: Severe acute respiratory syndrome: Prognostic implications of chest radiographic findings in 52 patients. Radiology 233: 173-81, 2004.

158.

Wu K.L., Lu S.N., Changchien C.S., Chiu K.W., Kuo C.H., Chuah S.K., Liu J.W., Lin M.C., Eng H.L., Chen S.S., Lee C.M.*, Chen C.L.: Sequential changes of serum aminotransferase levels in patients with severe acute respiratory syndrome. J Trop Med Hyg 71(2): 125-128, 2004.

157.

Lee C.M., Hsu C.Y., Eng H.L., Huang W.S., Lu S.N., Changchien C.S., Chen C.L., Chao C.L.: Telomerase activity and telomerase catalytic subunit in hepatocellular carcinoma. Hepatogastroenterology. 51: 796-800, 2004.

156.

Chang K.A., Luk H.N.*, Jawan B., Lu H.F., Chen H.S., Chen C.L. : Modified protective suits for anesthesiologists performing tracheal intubation for severe acute respiratory syndrome patient in Taiwan. Anesthesiology 100: 1630-1631, 2004.

155.

Pan T.L.* Wang P.W., Huang C.C., Goto S., Chen C.L.: Expression, by functional proteomics, of spontaneous tolerance in rat orthotopic liver transplantation. Immunology. 113: 57-64, 2004.

154.

Cheng K.W., Huang C.J., Wang C.H., Chen C.L., Jawan B.*: Anesthetic management of a patient with Alagille's syndrome undergoing living donor liver transplantation without blood transfusion. Chang Gung Med J. 27: 449-453, 2004.

153.

Nakano T., Kawamoto S.*, Lai C.Y., Sasaki T., Ak T., Shigeta S., Goto T., Sato S., Goto S., Chen C.L., Ono K.: Liver transplantation-induced antihistone H1 autoantibodies suppress mixed lymphocyte reaction. Transplantation. 77: 1595-1603, 2004.

152.

Chen C.H., Eng H.L., Lee C.M., Kuo F.Y., Lu S.N., Huang C.M., Tung H.D., Chen C.L., Changchien C.S.: Correlations between hepatitis B virus Genotype and cirrhotic or non-cirrhotic hepatoma. Hepatogastroenterology. 51: 552-555, 2004.

151.

Huang C.C., Chuang J.H.*, Huang L.L., Chou M.H., Wu C.L., Chen C.M., Hsieh C.S., Lee S.Y., Chen C.L.: The human delta-like I homologue is implicated in the progression of liver fibrosis in biliary atresia. J Pathol. 202: 172-179, 2004.

150.

Takatsuki M., Chen C.L.*, Chen Y.S., Cheng Y.F., Huang T.L.: Systemic thrombolytic therapy for late-onset portal vein thrombosis after living donor liver transplantation. Transplantation. 77: 1014-1018, 2004.

149.

Lin Y.T.*, Lin Y.T., Chen C.L.: A survey of the oral status of children undergoing liver transplantation. Chang Gung Med J. 26(3): 184-8, 2003.

148.

Tiao M.M.*, Ko S.F., Huang S.C., Shieh C.S., Chen C.L.: Urachal inflammatory mass mimicking an intra-abdominal tumor two years after excision of the urachal sinus in a child. Chang Gung Med J. 26(8): 598-601, 2003.

147.

Cheng Y.F.*, Chen C.L., Jawan B., Huang T.L., Chen T.Y., Chen Y.S., Wang C.C., de Villa V.H., Wang S.H., Wah C.K., Chiang Y.C., Eng H.L., Lee T.Y., Goto S.: Multislice computed tomography angiography in pediatric liver transplantation. Transplantation. 76 (2): 353-357, 2003.

146.

Jawan B.*, de Villa V.H., Luk H.N., Chen Y.S., Chiang Y.C., Wang C.C., Wang S.H., Cheng Y.F., Huang T.L., Eng H.L., Liu P.P., Chen C.L.: Ionized calcium changes during living-donor liver transplantation in patients with and without administration of blood-bank products. Transpl Int. Jul; 16 (7):510-514, 2003.

145.

Lan A.K., Luk H.N., Goto S., Chen S.M., Eng H.L., Chen Y.S., de Villa V.H., Wang C.C., Cheng Y.F., Chen C.L., Lee J.H., Jawan B.*: Stress response to hepatectomy in patients with a healthy or a diseased liver. World J Surg. 27(7):761-764, 2003.

144.

Cheng Y.F.*, Chen C.L., Chen T.Y., Huang T.L., Chen Y.S., Tsang L.L., Sun P.L.: Splenic embolization in treatment of portal vein occlusion deferring liver transplantation. Hepatogastroenterology. 50: 1614-1616, 2003.

143.

Chen T.Y., Huang T.L., Chen C.L., Chen Y.S., Weng H.H., Wang C.C., Lee T.Y., Cheng Y.F.*: Liver and spleen change in the living related liver donation. Transplant Proc. 35: 55-56, 2003.

142.

Huang T.L., Chen T.Y., Cheng Y.F., Weng H.H., Yu P.C., Lee T.Y., Chen Y.S., Wang C.C., Wang S.H., Chiu K.W., Chiang Y.C.*, Eng H.L., Jawan B., de Villa V.H., Chen C.L.: The significance of hepatic vein outflow volume in adult-to-adult living donor liver transplantation evaluated by Doppler ultrasound. Transplant Proc. 35: 68-69, 2003.

141.

Iwashita Y., Tahara K., Goto S.*, Sasaki A., Kai S., Seike M., Chen C.L., Kawano K., Kitano S.: A phase I study of autologous dendritic cells-based immunotherapy for patients with unresectable primary liver cancer. Cancer Immunol Immunother. 52:155-161, 2003.

140.

Jawan B., Goto S., Pan T.L., Lai C.Y., Luk H.N., Eng H.L., Lin Y.C., Lan K.M., Hsieh S.W., Wang C.C., Cheng Y.F., Chen C.L.*: The Protective mechanism of magnolol, a Chinese herb drug, against warm ischemia-Reperfusion injury of rat liver. J Surg Res. 110: 378-382, 2003.

139.

Chen T.Y., Chen C.L., Huang T.L., Chen Y.S., Wang C.C., de Villa V.H., Chiang Y.C., Jawan B., Cheng Y.F.*: Noninvasive multislice CT angiography in pediatric liver transplantation: A novel application. Transplant Proc. 35: 62-63, 2003.

138.

Jawan B.*, Luk H.N., Chen Y.S., Wang, C.C., Cheng Y.F., Huang T.L., Eng H.L., Liu P.P., Chiu K.W., Chen C.L.: The effect of liver graft-body weight ratio on the core temperature of pediatric patients during liver transplantation. Liver Transpl. 7: 760-763, 2003.

137.

Hsu L.W., Goto S., Lin Y.C., Lai C.Y., Tseng H.P., Wu C.L., Lord R., Kitano S., Chen S.H., Chen C.L.*: Prolongation of heart allograft survival of rats treated by a Th2 inhibitor. Transpl Immunol. 11: 385-388, 2003.

136.

de Villa V.H., Chen C.L.*, Chen Y.S., Wang C.C., Lin C.C., Cheng Y.F., Huang T.L., Jawan B., Eng H.L.: Right lobe living donor liver transplantation – addressing the middle hepatic vein controversy. Ann Surg. 238: 275-282, 2003.

135.

Huang F.C.*, Eng H.L., Chen C.L., Ko S.F.: Primary Pleomorphic rhabdomyosarcoma of the liver: a case report. Hepatogastroenterology. 50: 73-76, 2003.

134.

Iwashita Y., Goto S., Tahara K., Kawano K., Chen C.L., Kitano S.: Potent stimuli combined with lipopolysaccaride and IFNg may improve immunotherapy against HCC by increasing the maturation and subsequent immune response of the dendritic cells. Cancer Biother Radiopharm. 18: 1-6, 2003.

133.

Chuang F.R., Lee C.H.*, Chien Y.S., Chen Y.S. and Chen C.L.: Acute renal failure after living-related liver transplantation. Transplant Proc. 35: 429-430, 2003.

132.

Liu P.P., de Villa V.H., Chen Y.S., Wang C.C., Wang S.H., Chiang Y.C., Jawan B., Cheung H.K., Cheng Y.F., Huang T.L., Eng H.L., Chuang F.R., Chen C.L.*.: Outcome of living donor liver transplantation for glycogen storage disease. Transplant Proc. 35: 366-368, 2003.

131.

de Villa V.H., Chen Y.S., Chen C.L.*: Hepatitis B core antibody positive grafts-recipient’s risk. Transplantation. 75(3): S49-53, 2003.

130.

de Villa V.H., Lo C.M., Chen C.L.*: Ethics and rationale of live donor liver transplantation in Asia. Transplantation. 75(3): S2-5, 2003.

129.

Chen Y.S., Cheng Y.F., de Villa V.H., Wang C.C., Lin C.C., Huang T.L., Jawan B., Chen C.L.*: Evaluation of living liver donors. Transplantation. 75(3): S16-19, 2003.

128.

Chen C.L.*, Fan S.T., Lee S.G., Makuuchi M., Tanaka K.: Living donor liver transplantation: 12 years of experience in Asia. Transplantation. 75(3): S6-11, 2003.

127.

Chen C.L.*.: Living-donor liver transplantation-the Asian perspective. Guest editor’s comments. Transplantation. 75(3): S1, 2003.

126.

Huang W.T., Chen W.J., Chen C.L., Cheng Y.F., Wang J.H., Eng H.L.*: Endometrial cyst of the liver: a case report and review of the literature. J Clin Pathol. 55: 715-717, 2002.

125.

Chen Y.S., Wang C.C., de Villa V.H., Wang S.H., Cheng Y.F., Huang T.L., Jawan B., Chiu K.W., Chen C.L.*: Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors. Clin Transplant. 16: 405-409,2002.

124.

Lin C.L., LoW.F., Lee T.H., Ren Y., Hwang S.L., Cheng Y.F., Chen C.L.*, Chang Y.S., Lee S.P., Rickinson A.B., Tam P.K.: Immunization with Epstein-Barr virus (EBV) peptide-pulsed dendritic cells induces functional CD8 + T-cell immunity and may lead to tumor regression in patients with EBV-positive Nasopharyngeal carcinoma. Cancer Res. 62(23): 6952-6958, 2002.

123.

Jawan B., Goto S., Lai C.Y., de Villa V.H., Luk H.N., Eng H.L., Chen Y.S., Wang C.C., Cheng Y.F., Chen C.L.*: The effect of hypernatremia on liver allografts in rats. Anesth Analg. 95: 1169-1172, 2002.

122.

Ko S.F.*, Ng S.H., Lee T.Y., Wan Y.L., Lin J.W., Chen C.L.: Hepatic focal nodular hyperplasia: the “star sign” on gadolinium-enhanced magnetic resonance angiography. Hepatogastroenterology. 49: 1377-1381, 2002.

121.

Chen Y.S., Chen C.L.*, de Villa V.H., Wang C.C., Wang S.H., Liu P.P., Cheng Y.F., Huang T.L., Jawan B., Eng H.L.: Living donor liver transplantation in Taiwan. Current issues in liver and small bowel transplantation. Keio University International Symposium for Life Sciences and Medicine. 9:13-21, 2002.

120.

Chen C.L.*, de Villa V.H.: Split liver transplantation. (Review article) Asian J Surg. 25: 285-290, 2002.

119.

Cheng Y.F., Chen Y.S., Huang T.L., de Villa V.H., Chen T.Y., Lee T.Y., Wang C.C., Chiang Y.C., Eng H.L., Cheung H.K., Jawan B., Wang S.H., Goto S., Chen C.L.*: Interventional radiologic procedures in liver transplantation. Transpl Int. 14: 223-229, 2001.

118.

Lin Y.C., Goto S.*, Pan T.L., Hong Y.R., Lin C.L., Lord R., Chiang K.C., Lai C.Y., Tseng H.P., Hsu L.W., Iwashita S., Kitano S., Chen C.L.: Identification of two down-regulated genes in rat liver allografts by mRNA differential display. Transpl Int. 14: 153-158, 2001.

117.

Pan T.L., Goto S.*, Huang Y.C., Lord R., Huang C.M., Wang P.W., Kawamoto S., Ono K., Liao P.C., Lin C.L., Lai C.Y., Cheng H.L., Lan C.H., Lee T.H., Wang Y.H., Wu M.L., Jawan Y.F., Cheng S.T., Chen S.T., Chen S.T., Chen C.L.: Proteome analysis in liver transplantation. Transplant Proc. 33: 156, 2001.

116.

Takatsuki M., Chen C.L.*, de Villa V.H., Chen Y.S., Wang C.C., Wang S.H., Cheng Y.F., Huang T.L., Jawan B., Eng H.L.: Neoral-based immunosuppression in living donor liver transplantation. Transplant Proc. 33: 3450, 2001.

115.

Chen T.Y., Huang T.L., Chen C.L., Chen Y.S., Jawan B., Lee T.Y., Cheng Y.F.*: Vascular anomalies associated with biliary atresia in pretransplant survey. Transplant Proc. 33: 3470-3471, 2001.

114.

Huang T.L., Chen T.Y., Chen C.L., Chen Y.S., Wang C.C., Wang S.H., Chiu K.W., Chiang Y.C., Eng H.L., Jawan B., de Villa V.H., Weng H.H., Lee T.Y., Cheng Y.F.*: Hepatic outflow insults in living related liver transplantation: by Doppler sonography. Transplant Proc. 33: 3464-3465, 2001.

113.

Huang T.L., Chen C.L., Chen T.Y., Weng H.H., Lee T.Y., Chen Y.S., Chiang Y.C., Eng H.L., Wang C.C., Lin C.L., Wang S.H., Cheung H.K., Jawan B., de Villa V.H., Cheng Y.F.*: Doppler ultrasound in prediction of the early mortality risk factors on the waiting list for pediatric liver transplantation recipients. Transplant Proc. 33: 899-900, 2001.

112.

Cheng Y.F., Chen Y.S., Huang T.L., Chen T.Y., de Villa V.H., Lee T.Y., Wang C.C., Wang S.H., Chiang Y.C., Cheung H.K., Jawan B., Chen C.L.*: Biliary complications in living related liver transplantation. Chang Gung Med J. 24: 174-180, 2001.

111.

Cheng Y.F.*, Chen C.L., Huang T.L., Chen T.Y., Lee T.Y., Chen Y.S., Wang C.C., de Villa V.H., Goto S., Chiang Y.C., Eng. H.L., Jawan B., Cheung H.K.: Single imaging modality evaluation of living donors in liver transplantation: magnetic resonance imaging. Transplantation. 72: 1527-1533, 2001.

110.

Cheng Y.F., Chen C.L.*, Lai C.Y., Chen T.Y., Huang T.L., Lee T.Y., Lin C.L., Lord R., Chen Y.S., Eng H.L., Pan T.L., Lee T.H., Goto S.*: Assessment of donor fatty livers for liver transplantation. Transplantation. 71: 1221-1225, 2001.

109.

Liang C.D., Chen C.L.*, de Villa V.H., Tiao M.M., Cheng Y.F.: Successful liver transplantation in a child with biliary atresia and hepatopulmonary syndrome. J Formos Med Assoc. 100: 403-406, 2001.

108.

Tai D.I.*, Chung Z.J., Chen C.L., Eng H.L.: Reappearance of HBsAg with compartmentalized different HBV strains in allograft versus PBMC of the recipient. J Gastroenterol. 36: 200-205, 2001.

107.

Lord R.*, Goto S., Pan T.L., Chiang K.C., Chen C.L., Sunagawa M.: Peak protein expression of IL-2 and IFNγ correlate with the peak rejection episode in a spontaneously tolerant model of rat liver transplantation. Cytokine. 13: 155-161, 2001.

106.

de Villa V.H., Chen C.L.*, Chen Y.S., Wang C.C., Tan K.C., Suh K.S., Lee S.G., Tanaka K., Fan S.T.: Split liver transplantation in Asia. Transplant Proc. 33: 1502-1503, 2001.

105.

Cheng Y.F.*, Kan Z., Chen C.L., Huang T.L., Chen T.Y., Lee T.Y.: Efficacy and safety of preoperative lobar or segmental ablation via transarterial administration of ethiodol and ethanol mixture for treatment of hepatocellular carcinoma: clinical study. World J Surg 24:844-50, 2000.

104.

Chen T.Y., Chen C.L., Chen Y.S., Lee T.Y., Huang T.L., Hsu S.W., Lui C.C., Cheng Y.F.*: Asymptomatic vascular complications in liver transplantation. Transplant Proc. 32(7): 2252-3, 2000.

103.

Huang T.L.*, Cheng Y.F., Chen C.L., Lee T.Y., Chen T.Y., Chen Y.S., Chiang Y.C., Eng H.L., Wang C.C., Wang S.H., Lin C.L., Cheung H.K., Jawan B.: Intraoperative Doppler ultrasound in living-related liver transplantation. Transplantat Proc. 32: 2097-2098, 2000.

102.

Lui C.C.*, Chen C.L., Chang Y.F., Lee T.Y., Chuang Y.C. and Hsu S.P.: Subclinical Central Pontine Myelinolysis after Liver Transplantation. Transplant Proc. 32: 2215-2216, 2000.

101.

Wang S.H., Chen C.L.*, Chen Y.S., Wang C.C., de Villa V.H., Goto S., Chiang Y.C., Cheng Y.F., Huang T.L., Cheung H.K., Jawan B., Eng H.L.: Living donor liver transplantation: the Kaohsiung experience. Transplant Proc. 32: 2137-2138, 2000.

100.

de Villa V.H., Chen C.L.*, Chen Y.S., Wang C.C., Wang S.H., Goto S., Chiang Y.C., Cheng Y.F., Huang T.L., Jawan B., Cheung H.K., Eng H.L.: Initial experience with right lobe living donor liver transplantation. Transplant Proc. 32: 2158-2159, 2000.

99.

Cheng Y.F.*, Chen C.L., Chen Y.S., Huang T.L., Chen T.Y., Lee T.Y., Wang C.C., Chiang Y.C., Eng H.L., de Villa V.H., Lin C.L., Cheung H.K., Jawan B., Goto S.: Interventional radiology in the treatment of post-liver transplant complications. Transplant Proc. 32: 2196-2197, 2000.

98.

Eng H.L., Chen Y.S., Jawan B., Cheng Y.F., Chiang Y.C., Chen W.J., Huang T.L., Cheung H.K., Wang C.C., Lin C.L., Huang C.B., Chen C.L.*: Soluble thrombomodulin antigen as a marker for endothelial damage during liver transplantation. Transplant Proc. 32: 2273-2275, 2000.

97.

de Villa V.H., Chen C.L.*, Chen Y.S., Wang C.C., Wang S.H. Lin C.L., Chiang Y.C., Cheng Y.F., Huang T. L., Jawan B., Cheung H.K.: Outflow tract reconstruction in living donor liver transplantation. Transplantation. 70: 1604-1608, 2000.

96.

Pan T.L., Lin C.L., Chen C.L., Lin Y.C., Gojo S., Lee T.H., Wang Y.H., Lord R., Lai C.Y., Tsu L.W., Tseng H.P., Wu M.L., Iwashita Y., Kitano S., Chiang K.C., Hashimoto T., Sugioka A. Goto S.*: Identification of the indoleamine 2,3-dioxygenase nucleotide sequence in a a rat liver transplant model. Transpl Immunol. 8: 189-194, 2000.

95.

Yokoyama H., Goto S.*, Chen C.L., Pan T.L., Kawano K., Kitano S.: Major hepatic resection may suppress the growth of tumours remaining in the residual liver. Br J Cancer. 83: 1096-1101, 2000.

94.

Tatsuma T., Goto S., Kitano S., Lin Y.C., Lee C.M., Chen C.L.*: Telomerase activity in peripheral blood for diagnosis of hepatoma. J Gastroenterol Hepatol. 15: 1064-1070, 2000.

93.

Goto S., Lin Y.C., Lin C.L., Lord R., Lee C.M., Pan T.L., Chiang K.C., Lai C.Y., Tseng H.P., Shu L.W., Huang H.Y., Lee T.H., Yokoyama H., Kitano S., Chen C.L.*: Activation of telomerase by liver transplantation in rats. Transplant Proc. 32: 2376-2377, 2000.

92.

Pan T.L., Chen C.L., Lin C.L., Lai C.Y., Tseng H.P., Chiang K.C., Lin Y.C., Shu L.W., Chen Y.S., Eng H.L., Jawan B., Yokoyama H., Kitano S., Goto S.*: Ceruloplasmin, a novel candidate as a diagnostic marker for liver function after liver transplantation. Transplant Proc. 32: 2198, 2000.

91.

Chiang K.C., Chen C.L., Lin Y.C., Lin C.L., Pan T.L., Lord R., Lai C.Y., Tseng H.P., Huang H.Y., Yokoyama H., Kitano S., Goto S.*: Expression .of clusterin in a rat tolerogenic OLT model. Transplant Proc. 32: 2333-2334, 2000.

90.

Chiang K.C.*, Goto S., Chen C.L., Lin C.L., Lin Y.C., Pan T.L., Lord R., Lai C.Y., Tseng H.P., Hsu L.W., Lee T.H., Yokoyama H., Kunimatsu M, Chiang Y.C. and Hashimoto. T.: Clusterin may be involved in rat liver allograft tolerance. Transpl Immunol. 8: 95-99, 2000.

89.

Jawan B.*, Cheung H.K., Chen C.L., Chen Y.S., Chiang Y.C., Wang C.C., Cheng Y.F., Huang T.L., Eng H.L., Goto S., Pan T.L., de Villa V.H., Liu P.P., Wang S.H., Lin C.L., Lee J.H.: Repeated hypotensive episodes due to hepatic outflow obstruction during liver transplantation in adult patients. J Clin Anesth. 12: 231-233, 2000.

88.

de Villa V.H., Chen C.L.*, Chen Y.S., Wang C.C., Wang S.H., Chiang Y.C., Cheng Y.F., Jawan B., Cheung H.K., Fan S.T., Lo C.M.: International sharing of split liver grafts in Asia: Initial experience. Clin Transplant. 14: 355-359, 2000.

87.

Goto S., Lin Y.C., Lai C.Y., Lee C.M., Pan T.L., Lord R., Chiang K.C., Lai C.Y., Tseng H.P., Lin C.L., Cheng Y.F., Yokoyama H., Kitano S., Chen C.L.*: Telomerase activity in rat liver allografts. Transplantation. 69: 1013-1015, 2000.

86.

Chen C.L.*, Chen Y.S., de Villa V.H., Wang C.C., Lin C.L., Goto S., Wang S.H., Cheng Y.F., Huang T.L., Jawan B., Cheung H.K.: Minimal blood loss living donor hepatectomy. Transplantation. 69: 2580-2586, 2000.

85.

Chen C.L.*, Chen Y.S., Goto S., Jawan B., Cheng Y.F., Eng. H.L.: Successful transplantation for a patient with ruptured large hepatocellular carcinoma with diaphragmatic invasion. Surgery. 127:228-229 2000.

84.

Cheng Y.F.*, Chen C.L., Huang T.L., Chen T.Y., Lee Z.Y., Chen Y.S., Wang C.C., de Villa V., Goto S., Chiang Y.C., Eng H.L., Cheung H.K., Jawan B.: Magnetic resonance of the hepatic veins with angular reconstruction: application in living related liver transplantation. Transplantation. 68: 267-271, 1999.

83.

Lord R.*, Goto S., Vari F., Pan T.L., Chiang K.C., Chen C.L., Sunagawa M.: Immunization with a synthetic peptide conjugate derived from the N-terminal sequence of either the beta-chair of hemoglobin or the immunosuppressive protein (re OLT4) reduces the litter size of pregnant rats. Scan J Immunol. 49: 162-168, 1999.

82.

Pan T.L., Goto S.*, Lin Y.C., Lord R., Chiang K.C., Lai C.Y., Chen Y.S., Eng H.L, Cheng Y.F., Tatsuma T., Kitano S., Lin C.L., Chen C.L.: The Fas and Fas ligand pathways in liver allograft tolerance. Clin Exp Immunol. 118: 180-187, 1999.

81.

Goto S.*, Vari F., Lord R., Edwards-Smith C., Chiba S., Kobayashi S., Pan T.L., Lin Y.C., Chiang K.C., Lai C.Y., Tatsuma T., Kitano S., Chen C.L.: The mechanisms of suppression of liver allograft rejection by LSF-1. Transplant Proc. 31: 451-452, 1999.

80.

Hsiao C.C.*, Chen C.L., Eng H.L.: Inflammatory pseudotumor of the liver in Kostmanns’ disease: Report of one case and review of literature. Pediatr Surg Int. 15: 266-269, 1999.

79.

Lee C.M.*, Lu S.N., Changchien C.S., Yeh C.T., Hsu T.T., Tang J.H., Wang J.H., Lin D.Y., Chen C.L., Chen W.J.: Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection. Cancer. 86: 1143-1150, 1999.

78.

Cheng Y.F., Chen C.L., Huang T.L., Lee T.Y., Chen T.Y., Chen Y.S., Liu P.P., Chiang Y.C., Eng H.L., Wang C.C., Cheung H.K., Jawan B., Goto S.: Post-transplant changes of segment 4 after living related liver transplantation. Clin Transplant. 12: 476-481, 1998.

77.

Tsai M.Y.*, Chang S.Y., Hsiu D.Y., Gong F.T., Chen C.L.: Pregnancy after orthotopic liver transplantation in a Chinese patient: A Case Report. Chang Gung Med J. 21: 67-71, 1998.

76.

Goto S.*, Noguch T., Morotomi Y., Lord R., Board J., Chen C.L., Jawan B., Pan T.L., Chen Y.S., Tatsuma T., Kitano S., Lynch S.V.: A transient increase in endogeneous erythropoietin levels after pediatric liver transplantation. Transplant Immunol. 6: 265-267, 1998.

75.

Pan T.L., Goto S.*, Matsumoto I., Wilce P., Lord R., Kobayashi S., Lin Y.C., Chiang K.C., Lai C.Y., Jawan B.,Chen C.L.: Immediate early genes and AP-1 DNA binding activity in rat liver ischemia. Transplant Proc. 30: 3721-3722, 1998.

74.

Kobayashi S., Goto S.*, Lord R., Shimizu Y., Swanson C., Vari F., Edwards-Smith C., Chiba S., Pan T.L., Chen C.L.: Analysis of immunosuppressive proteins in serum of liver-transplanted rats by using anti-LSF-1 affinity. J Surg Res. 80: 58-61, 1998.

73.

Cheng Y.F., Huang T.L., Chen C.L., Lee T.Y., Chen T.Y., Chen Y.S., Liu P.P., Chiang Y.C., Eng H.L., Wang C.C., Cheung H.K., Jawan B, Goto S.: Intraoperative Doppler ultrasound in liver transplantation. Clin Transplant. 12: 292-299, 1998.

72.

Eng H.L.*, Chen C.L., Chen W.J., Cheng Y.F., Chen Y.S., Huang T.L., Liu P.P., Jawan B. Chiang Y.C., Wang C.C.: Histopathology in pediatric recipients of living related liver transplantation. Transplant Proc. 30: 3265-3267, 1998.

71.

Cheng Y.F.*, Chen C.L.,Huang T.L., Lee T.Y., Chen T.Y., Chen Y.S., Eng H.L., Liu P.P., Chiang Y.C., Wang C.C., Cheung H.K., Jawan B.: Radiologic anatomy in split liver transplantation. Transplant Proc. 30: 3184-3185, 1998.

70.

Huang T.L.*, Cheng Y.F., Chen C.L., Lee T.Y., Chen T.Y., Chen Y.S., Eng H.L., Liu P.P., Chiang Y.C., Wang C.C., Cheung H.K., Jawan B.: Portal hemodynamics in living related liver transplantation: quantitative measurement by Doppler ultrasonography. Transplant Proc. 30: 3186-3187, 1998.

69.

Chen T.Y.*, Cheng Y.F., Huang T.L., Lee T.Y., Yu P.C., Chen C.L., Chen Y.S., Eng H.L.: Preoperative assessment of the portal vein in potential pediatric liver transplantation recipients: comparison of sonography and invasive portography. Transplant Proc. 30: 3195-3196, 1998.

68.

Chen Y.S.*, Chen C.L., Liu P.P., Chiang Y.C., Wang C.C., Goto S., Cheng Y.F., Huang T.L., Eng H.L., Cheung H.K.: Successful treatment of hepatic vein thrombosis following reduced-size liver transplantation. Transplant Proc. 30: 3203-3204, 1998.

67.

Lui C.C.*, Chen C.L., Chen Y.F., Lee T.Y.: Recovery of neurological deficits in a case of Wilson’s disease after liver transplantation. Transplant Proc. 30: 3324-3325, 1998.

66.

Liu P.P., Chen C.L.*, Chen Y.S., Chiang Y.C., Wang C.C., Eng H.L.: Neoral-based immunosuppression in living related liver transplantation. Transplant Proc. 30: 3550-3551, 1998.

65.

Chiang Y.C.*, Chen C.L., Chen Y.S., Liu P.P., Wang C.C.: Plastic surgery in liver transplantation. Transplant Proc. 30: 3173-3175, 1998.

64.

Cheng Y.F.*, Huang T.L., Chen T.Y., Lee T.Y., Chen Y.S., Eng H.L., Liu P.P., Chiang Y.C., Wang C.C., Cheung H.K., Jawan B., Goto S., Chen C.L.: Outcome of medical segment in partial liver grafting. Transplant Proc .30: 3250-3251, 1998.

63.

Chen Y.S., Chen C.L.*, Liu P.P., Chiang Y.C., Wang C.C., Goto S., Cheng Y.F., Huang T.L., Eng H.L., Cheung H.K., Jawan B.: Pediatric liver transplantation from living related donors. Transplant Proc. 30: 3252-3253, 1998.

62.

Chiba S.*, Goto S., Lord R., Chen C.L., Ochiai T., Isono K.: Role of passenger leukocytes on the induction of tolerance in rat liver transplantation. Transplant Proc. 30: 3852-3853, 1998.

61.

Chiang K.C., Pan T.L., Goto S.*, Lin Y.C., Lai C.Y., Liu P.P., Chen Y.S., Wang C.C., Chiang Y.C., Cheng Y.F., Huang T.L., Eng H.L., Cheung H.K., Jawan B., Chen C.L.: Differential expression of protein associated with liver transplantation in Wilson’s disease patient. Transplant Proc. 30: 3263-3264, 1998.

60.

Goto S.*, Noguchi T., Lynch S.V., Strong RW, Morotomi Y., Lord R., Kobayashi S., Eng H.L., Chen Y.S., Liu P.P., Wan C.C., Pan T.L., Cheung H.K., Jawan B., Chen C.L.: Is regular measurement of adhesion molecules and cytokines useful to predict post-liver transplant complications? Transplant Proc. 30: 2975-2976, 1998.

59.

Goto S.*, Lord R., Shimizu Y., Edwards-Smith C., Vari F., Chiba S., Kobayashi S., Pan T.L., Akiyama K., Kuwahara T., Yuda H., Goto T., Chiang K.C., Lin Y.C., Chen C.L.: The suppression of heart and liver allograft rejection by liver suppressor factor one (LSF-1) and its possible human homologue. Transplant Proc. 30: 3578-3579, 1998.

58.

Liu P.P., Chen C.L.*, Chen Y.S., Wang C.C. , Chiang Y.C., Goto S., Cheng Y.F., Huang T.L., Eng. H.L., Cheung H.K., Jawan B.: Experience with liver transplantation in Taiwan. Transplant Proc. 30: 3178-3179, 1998.

57.

Chen C.L.*, Liu P.P., Chen Y.S., Wang C.C., Chiang Y.C., Goto S., Cheng Y.F. Huang T.L., Eng H.L., Cheung H.K., Jawan B.: Initiation of split liver transplantation in Taiwan. Transplant Proc. 30: 3249, 1998.

56.

Liu P.P., Chen C.L., Eng H.L., Chen Y.S., Chiang Y.C.,: Lymphoproliferative discorder after liver transplantation. J Formos Med Assoc. 97: 59-62, 1998.

55.

Cheng Y.F.*, Chen C.L., Huang T.L., Lee T.Y., Chen T.Y., Chen Y.S., Liu P.P., Chiang Y.C., Eng. H.L., Cheung H.K., Jawan B.: Imaging in pediatric liver transplantation. Acta Paed Sin. 38: 255-259, 1997.

54.

Eng H.L.*, Chen C.L., Chen W.J., Chen Y.S., Chiang Y.C., Cheng Y.F., Huang T.L., Liu P.P., Jawan B., Cheung H.K., Lee N., Huang C.B., Wang C.C.: Histopathology of the liver in pediatric patients following transplantation. Acta Paed Sin. 38: 260-266, 1997.

53.

Chou F.F.*, Sheen-Chen S.M., Chen Y.S., Chen M.C., Chen C.L.: Surgical treatment of cholangiocarcinoma. Hepatogastroenterology 44:760-765, 1997.

52.

Cheng Y.F., Huang T.L., Chen C.L., Chen Y.S., Lee T.Y.: Variations of the intrahepatic bile ducts: Application in living related liver transplantation and splitting liver transplantation. Clin Transplant. 11: 337-340, 1997.

51.

Cheng Y.F., Huang T.L., Chen C.L., Chen T.Y., Huang C.C., Ko S.F., Yang B.Y., Lee T.Y.: Variations of the middle and inferior right hepatic vein: Application in hepatectomy. J Clin Ultrasound. 25: 175-182, 1997.

50.

Cheng Y.F., Lee T.Y., Chen C.L., Huang T.L., Chen Y.S., Lui C.C.: Three-dimensional helical computed tomographic cholangiography application to living related hepatic transplantation. Clin Transplant. 11: 209-213, 1997.

49.

Cheng Y.F., Huang T.L., Lui C.C., Lee T.Y., Chen C.L.: Magnetic resonance venography in potential pediatric liver transplant recipients. Clin Transplant. 11: 121-126, 1997.

48.

Cheng Y.F.*, Huang T.L., Chen C.L., Sheen-Chen S.M., Lui C.C., Chen T.Y., Lee T.Y.: Anatomic dissection between the intrahepatic bile duct and portal vein: Risk factors for left hepatectomy. World J Surg21: 297-300, 1997.

47.

Chen C.L.*, Chen Y.S., Liu P.P., Chiang Y.C., Cheng Y.F., Huang T.L., Eng H.L.: Living related donor liver transplantation. J Gastroen Hepatol. 12: S342-345, 1997.

46.

Chen C.L.*, Chen Y.S., Lui C.C., Hsu S.P.: Neurological improvement of Wilson disease after liver transplantation. Transplant Proc. 29: 497-498, 1997.

45.

Cheng Y.F., Huang T.L., Lee T.Y., Chen T.Y., Chen C.L.: Overview of the imagings in living related donor hepatic transplantation. Transplant Proc. 28: 2412-2414, 1996.

44.

Cheng Y.F., Chen C.L., Huang T.L., Lee T.Y.: Computed tomographic cholangio-graphy: Application in living related hepatic transplantation. Transplant Proc. 28: 2397-2398, 1996.

43.

Chiang Y.C., Chen C.L., Chen Y.S., Liu P.P., Cheng Y.F., Huang T.L., Eng H.L.: Hepatic artery reconstruction using microsurgical technique in liver transplantation. Transplant Proc. 28: 2417-2419, 1996.

42.

Chen Y.S., Chen C.L., Liu P.P., Chiang Y.C., Cheng Y.F., Huang T.L., Eng H.L.: Preoperative evaluation of living related liver transplantation. Transplant Proc. 28: 2415-2416, 1996.

41.

Chen C.L.*, Chen Y.S., Liu P.P., Chiang Y.C., Cheng Y.F., Huang T.L., Eng H.L.: Living related donor liver transplantation: The Kaohsiung Experience. Transplant Proc. 28: 2385-2387, 1996.

40.

Chen C.L.*: Introductory remarks of the first international symposium on living related liver transplantation. Transplant Proc. 28: 2365, 1996.

39.

Eng H.L., Chen C.L., Lee N., Chen Y.S., Chen W.J.: Histopathology of liver following transplantation: An experience in Taiwan. Transplant Proc. 28: 1689-1690, 1996.

38.

Huang T.L., Cheng Y.F., Lee T.Y., Chen C.L.: Variant of the bile ducts based on the ERC interpretation in 958 cases: the clinical application in the potential donor of living related hepatic transplantation. Transplant Proc. 28: 1669-1670, 1996.

37.

Cheng Y.F., Huang T.L., Lee T.Y., K Chen T.Y., Chen C.L.: Variation of the intrahepatic portal vein, angiographic demonstration: Application in living related hepatic transplantation. Transplant Proc. 28: 1667-1668, 1996.

36.

Lui C.C., Chen C.L., Lee R.J., Lee T.Y.: Changes of neuroimages in Wilson's disease following orthotopic liver transplantation. Transplant Proc. 28: 1710-1713,1996.

35.

Sun C.K., Chen C.L., Chen Y.S.: Reoperative procedures after orthotopic liver transplantation. Transplant Proc. 28: 1676-1678, 1996.

34.

Chen Y.S., Chen C.L., Chiang Y.C., Liu P.P.: Successful management of invasive mucormycosis following liver transplantation. Transplant Proc. 28: 1708-1709, 1996.

33.

Liu P.P., Chen C.L., Chen Y.S., Tai D.I.: De novo HBV infection after orthotopic liver transplantation. Transplant Proc. 28: 1684-1686, 1996.

32.

Chen Y.S., Chen C.L., Chiang Y.C., Liu P.P.: Liver Transplantation of biliary atresia. Transplant Proc. 28: 1665-1666, 1996.

31.

Chen C.L.*, Chen Y.S., Chiang Y.C., Liu P.P., Cheng Y.F., Huang T.L., Eng H.L. Cheung H.K., Jawan B., Lee J.H.: Initiation of living related liver transplantation in Taiwan. Transplant Proc. 28: 1704-1705, 1996.

30.

Chen C.L.*, Chen Y.S., Chiang Y.C., Liu P.P., Cheng Y.F., Huang T.L., Eng H.L.: Translocation of a liver transplant program to southern Taiwan. Transplant Proc. 28: 1717-1718, 1996.

29.

Chen C.L.*, Chen Y.S., Chiang Y.C., Sun C.K., Cheng Y.F., Huang T.L., Eng H.L.: Pediatric liver transplantation: A ten year experience in Taiwan. J Gastroen Hepatol. S2: S1-3, 1996.

28.

Cheng Y.F., Huang T.L., Chen C.L., Chen T.Y., Huang C.C., Ko S.F., Lee T.Y.: Variations of the left and middle hepatic veins: Application in living related hepatic transplantation. J Clin Ultrasound. 24: 11-16, 1996.

27.

Chou F.F., Chen C.L., Sheen-Chen S.M., Chen Y.S., Chen M.C.: Ultrasonic dissection in resection of hepatocellular carcinoma. Int Surg. 80: 105, 1995.

26.

Chou F.F., Sheen-Chen S.M., Chen C.L., Chen Y.S., Chen M.J.: Prognostic factors after hepatectomy for hepatocellular carcinoma. Hepatogastroenterology. 41: 419-423, 1994.

25.

Hui Y.L., Wu Y.W., Chen C.L.: Experiences of pain control for liver transplants. Transplant Proc. 26: 2235-2236, 1994.

24.

Kuo Y.C., Chen C.L.*, Sun C.K., Chen Y.S.: Liver Transplantation against positive lymphocytotoxic crossmatches. Transplant Proc. 26: 2248-2249, 1994.

23.

Sun C.K., Chen C.L.*, Kuo Y.C., Chen Y.S.: Intensive care after orthotopic liver transplantation. Transplant Proc. 26: 2246-2247, 1994.

22.

Chen Y.S., Chen C.L., Kuo Y.C., Sun C.K.: Cytomegalovirus infection after liver transplantation. Transplant Proc. 26: 2229-2230, 1994.

21.

Chen C.L.*, Sun C.K.: Quality of life following orthotopic liver transplantation. Transplant Proc. 26: 2266-2268, 1994.

20.

Chen C.L.*, Eng H.L., Chen Y.S., Kuo Y.C., Sun C.K.: FK506 used as rescue therapy for refactory liver allograft rejection. Transplant Proc. 26: 1927-1929, 1994.

19.

Chen C.L.*, Chen Y.S., Kuo Y.C., Sun C.K. Wang K.L.: Orthotopic liver transplantation: A ten year experience. Transplant Proc. 26: 2252-2253, 1994.

18.

Kawarasaki H., Iwanaka T., Tsuchida Y., Kanamori Y., Tanaka K., Utsuki T., Komuro H., Chen C.L., Kawasaki S., Ishizone S., Matsunami H., Makuuchi M.: Partial liver transplantation from a living donor: Experimental research and clinical experience. J Pediatr Surg. 29: 518-522, 1994.

17.

Chen C.L.*, Kuo Y.C.: Metabolic effects of liver transplantation in Wilson's disease. Transplant Proc. 25: 2944-2947, 1993..

16.

Chen C.L.*: Liver Transplantation. Chang Gung Nursing Journal 3: 1-3, 1992.

15.

Chen C.L.*, Wang K.L., Hui Y.L., Shieh W.B.: Liver Transplantation in Taiwan: The Chang Gung experience. Cancer Chemother Pharmacol. 31: S162-165, 1992.

14.

Song H.S., Ku W.C., Chen C.L.: Disappearance of Kayser-Fleischer rings following liver transplantation. Transplant Proc. 24:1483-1485, 1992.

13.

Chu K.K., Chen C.L.: Abatement of secondary amenorrhea in Wilson's disease following liver transplantation. Transplant Proc. 24: 1468-1469, 1992.

12.

Wang K.L., Chen C.L.: Biliary complications following orthotopic liver transplantation. Transplant Proc. 24: 1481-1482, 1992.

11.

Shieh W.B., Chen C.L., Wang K.L.: Respiratory changes and pulmonary complications following orthotopic liver transplantation. Transplant Proc. 24: 1486-1488, 1992.

10.

Hui Y.L., Wu Y.W., Chen C.L.: Experience in anesthesia for liver transplantation. Transplant Proc. 24: 1473-1474, 1992.

9.

Chen C.L.*, Wang K.L., Li C.T., Kou Y.C., Hui Y.L., Wu Y.W., Yen C.L., Fang K.M., Shieh W.B.: Liver Transplantation: the Chang Gung experience. Transplant Proc. 24: 1479-1480, 1992.

8.

Kawarasaki H., Iwanaka T., Nakajo T., Hashizume K., Chen C.L., Makuuchi M., Hori T., Uno T.: Live related partial liver transplantation with monkeys and clinical report of two cases. Japanese Journal of Pediatric Surgery 22: 966-937, 1990.

7.

Chen C.L.*, Fang K.M., Hui Y.L.: Experience with major hepatic resections for hepatocellular carcinoma. Cancer Chemother Pharmacol. 23: S101-103, 1989.

6.

Chen C.L. *, Wang K.L., Chuang J.H., Lin J.N., Chang C.H.: Successful liver transplantation against positive T cell warm crossmatch. Asian J Surg. 12: 31-33, 1989.

5.

Chen C.L.*: Liver transplantation in Asian. Journal of Medical Association, R.O.C. 31: 54-56, 1988.

4.

Chen C.L.*, Wang K.L., Chuang J.H., Lin J.N., Chen M.F., Chang C.H.: Biliary sludge-cast formation following liver transplantation. Hepatogastroenterology. 35: 22-24, 1988.

3.

Chen C.L.*, Wang K.L., Lee M.C., Chuang J.H., Jan Y.Y., Lin J.N., Chen M.F., Chang C.H., Lin D.Y. Liaw Y.F., Au C., Chu N.S., Lee T.Y., Wong K.M., Hui Y.L., Tan P.P.C.: Liver transplantation for Wilson's disease -- Report of the first successful liver transplant in Taiwan. Japanese Journal of Transplantation. 22:178-184, 1987.

2.

Chen C.L.*, Wang K.L., Lin J.N., Chen M.F., Chang C.H.: Liver transplantation for Wilson's disease -- Report of the first two successful liver transplants in Taiwan. Proceedings of the Second Asian Cyclosporine Workshop. Edited by Kahan B.D. pp. 96-110, Excerpta Medica, 1986.

1.

Chu N.S.*, Yang S.S., Chen C.L.: Somatosensory evoked potentials: Monitoring cerebral functions following liver transplantation. Clinical Electroencephalogr. 16:192-194, 1985.